mch10q-063008.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
[ü]
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
|
SECURITIES
EXCHANGE ACT OF 1934
For the
quarterly period ended June 30, 2008
OR
[
]
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
|
SECURITIES
EXCHANGE ACT OF 1934
For the
transition period from . . . . . . . . . . to . . . . . . . . . .
Commission
file number 1-12091
MILLENNIUM
CHEMICALS INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
22-3436215
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
|
|
Two
Greenville Crossing, 4001 Kennett Pike
|
19807
|
Suite 238, Greenville,
Delaware
|
(Zip
Code)
|
(Address
of principal executive offices)
|
|
Registrant's
telephone number, including area code: (713) 652-7200
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes __ No ü
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See definitions of “large accelerated filer,” “accelerated
filer” and “smaller reporting company” in Rule 12b-2 of the Exchange
Act. (Check one):
Large
accelerated filer __ Accelerated filer
__ Non-accelerated
filer ü Smaller
reporting company __
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes __ No
ü
Number of
shares of common stock outstanding as of June 30,
2008: 661. There is no established public trading
market for the registrant’s common stock.
The
Registrant meets the conditions set forth in General Instructions H(1)(a) and
(b) of Form 10-Q and, therefore, is filing this form with a reduced disclosure
format.
PART
I. FINANCIAL INFORMATION
ITEM
1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
MILLENNIUM
CHEMICALS INC.
CONSOLIDATED
STATEMENTS OF INCOME
|
|
Successor
|
|
|
Predecessor
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the three months ended
|
|
|
For
the six months ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Sales
and other operating revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade
|
|
$ |
170 |
|
|
$ |
146 |
|
|
$ |
356 |
|
|
$ |
280 |
|
Related
parties
|
|
|
23 |
|
|
|
15 |
|
|
|
43 |
|
|
|
33 |
|
|
|
|
193 |
|
|
|
161 |
|
|
|
399 |
|
|
|
313 |
|
Operating
costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of sales
|
|
|
164 |
|
|
|
142 |
|
|
|
323 |
|
|
|
264 |
|
Selling,
general and administrative expenses
|
|
|
10 |
|
|
|
22 |
|
|
|
18 |
|
|
|
34 |
|
Research
and development expenses
|
|
|
-
- |
|
|
|
1 |
|
|
|
1 |
|
|
|
2 |
|
|
|
|
174 |
|
|
|
165 |
|
|
|
342 |
|
|
|
300 |
|
Operating
income (loss)
|
|
|
19 |
|
|
|
(4 |
) |
|
|
57 |
|
|
|
13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related
parties
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(1 |
) |
|
|
-
- |
|
Interest
expense on push-down debt
|
|
|
(8 |
) |
|
|
-
- |
|
|
|
(15 |
) |
|
|
-
- |
|
Millennium
debt
|
|
|
(6 |
) |
|
|
(19 |
) |
|
|
(12 |
) |
|
|
(38 |
) |
Interest
income
|
|
|
1 |
|
|
|
6 |
|
|
|
1 |
|
|
|
7 |
|
Other
income (expense), net
|
|
|
(1 |
) |
|
|
(16 |
) |
|
|
2 |
|
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from continuing operations before equity
investment and income taxes
|
|
|
5 |
|
|
|
(33 |
) |
|
|
32 |
|
|
|
(34 |
) |
Income
(loss) from equity investment in
Equistar Chemicals, LP
|
|
|
(62 |
) |
|
|
3 |
|
|
|
(96 |
) |
|
|
6 |
|
Effect
of push-down debt on loss from equity investment in Equistar Chemicals,
LP
|
|
|
62 |
|
|
|
-
- |
|
|
|
96 |
|
|
|
-
- |
|
Income
(loss) from continuing operations before
income taxes
|
|
|
5 |
|
|
|
(30 |
) |
|
|
32 |
|
|
|
(28 |
) |
Provision
for (benefit from) income taxes
|
|
|
2 |
|
|
|
(13 |
) |
|
|
12 |
|
|
|
(12 |
) |
Income
(loss) from continuing operations
|
|
|
3 |
|
|
|
(17 |
) |
|
|
20 |
|
|
|
(16 |
) |
Income
from discontinued operations, net of tax
|
|
|
-
- |
|
|
|
283 |
|
|
|
-
- |
|
|
|
297 |
|
Net
income
|
|
$ |
3 |
|
|
$ |
266 |
|
|
$ |
20 |
|
|
$ |
281 |
|
See Notes
to the Consolidated Financial Statements.
MILLENNIUM
CHEMICALS INC.
CONSOLIDATED
BALANCE SHEETS
Millions of dollars,
except shares and par value data
|
|
June
30,
2008
|
|
|
December
31, 2007
|
|
ASSETS
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$ |
29 |
|
|
$ |
51 |
|
Accounts
receivable:
|
|
|
|
|
|
|
|
|
Trade,
net
|
|
|
104 |
|
|
|
106 |
|
Related
parties
|
|
|
23 |
|
|
|
17 |
|
Inventories
|
|
|
131 |
|
|
|
104 |
|
Prepaid
expenses and other current assets
|
|
|
73 |
|
|
|
73 |
|
Deferred
tax assets
|
|
|
9 |
|
|
|
9 |
|
Notes
receivable from related party
|
|
|
-
- |
|
|
|
80 |
|
Total
current assets
|
|
|
369 |
|
|
|
440 |
|
|
|
|
|
|
|
|
|
|
Property,
plant and equipment, net
|
|
|
312 |
|
|
|
310 |
|
Investment
in Equistar Chemicals, LP
|
|
|
|
|
|
|
|
|
Prior
to push-down debt
|
|
|
1,556 |
|
|
|
1,652 |
|
Effect
of push-down debt
|
|
|
(1,556 |
) |
|
|
(1,652 |
) |
Net
investment in Equistar Chemicals, LP
|
|
|
-
- |
|
|
|
-
- |
|
Other
investments and long-term receivables
|
|
|
16 |
|
|
|
16 |
|
Other
assets, net
|
|
|
177 |
|
|
|
193 |
|
Total
assets
|
|
$ |
874 |
|
|
$ |
959 |
|
See Notes
to the Consolidated Financial Statements.
MILLENNIUM
CHEMICALS INC.
CONSOLIDATED
BALANCE SHEETS – (Continued)
|
|
June
30,
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Millions of dollars,
except shares and par value data
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDER’S EQUITY
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
Current
maturities of long-term debt
|
|
$ |
- - |
|
|
$ |
158 |
|
Notes
payable to related party
|
|
|
25 |
|
|
|
-
- |
|
Accounts
payable:
|
|
|
|
|
|
|
|
|
Trade
|
|
|
87 |
|
|
|
79 |
|
Related
parties
|
|
|
26 |
|
|
|
23 |
|
Accrued
liabilities
|
|
|
62 |
|
|
|
75 |
|
Deferred
income taxes
|
|
|
4 |
|
|
|
4 |
|
Total
current liabilities
|
|
|
204 |
|
|
|
339 |
|
Long-term
debt:
|
|
|
|
|
|
|
|
|
Push
down
|
|
|
316 |
|
|
|
350 |
|
Debt
of Millennium
|
|
|
171 |
|
|
|
170 |
|
Other
liabilities
|
|
|
228 |
|
|
|
238 |
|
Deferred
income taxes
|
|
|
238 |
|
|
|
221 |
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
Minority
interest
|
|
|
7 |
|
|
|
7 |
|
Stockholder’s
equity:
|
|
|
|
|
|
|
|
|
Common
stock, $0.01 par value, 1,000 shares authorized,
661
shares issued at June 30, 2008 and December 31,
2007
|
|
|
-
- |
|
|
|
-
- |
|
Additional
paid-in capital
|
|
|
1,752 |
|
|
|
1,745 |
|
Retained
earnings (deficit)
|
|
|
14 |
|
|
|
(6 |
) |
Push
down debt
|
|
|
(1,966 |
) |
|
|
(2,015 |
) |
Treasury
stock, at cost, 48 shares issued at June 30, 2008 and
December 31,
2007
|
|
|
(90 |
) |
|
|
(90 |
) |
Total
stockholder’s equity
|
|
|
(290 |
) |
|
|
(366 |
) |
Total
liabilities and stockholder’s equity
|
|
$ |
874 |
|
|
$ |
959 |
|
See Notes
to the Consolidated Financial Statements.
MILLENNIUM
CHEMICALS INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the six months ended
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
income
|
|
$ |
20 |
|
|
$ |
281 |
|
Income
from discontinued operations, net of tax
|
|
|
-
- |
|
|
|
(297 |
) |
Adjustments
to reconcile net income to
cash
provided by (used in) operating activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
26 |
|
|
|
17 |
|
Equity
investment in Equistar Chemicals, LP –
|
|
|
|
|
|
|
|
|
Amount
included in net income
|
|
|
96 |
|
|
|
(6 |
) |
Distribution
of earnings
|
|
|
-
- |
|
|
|
6 |
|
Push-down
debt
|
|
|
(96 |
) |
|
|
-
- |
|
Interest
on push-down debt
|
|
|
15 |
|
|
|
-
- |
|
Deferred
income taxes
|
|
|
11 |
|
|
|
38 |
|
Debt
prepayment premiums and charges
|
|
|
-
- |
|
|
|
14 |
|
Changes
in assets and liabilities that provided (used) cash:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(4 |
) |
|
|
(17 |
) |
Inventories
|
|
|
(27 |
) |
|
|
(5 |
) |
Accounts
payable
|
|
|
13 |
|
|
|
(1 |
) |
Other,
net
|
|
|
(31 |
) |
|
|
(129 |
) |
Net
cash provided by (used in) operating activities – continuing
operations
|
|
|
23 |
|
|
|
(99 |
) |
Net
cash used in operating activities – discontinued
operations
|
|
|
-
- |
|
|
|
(120 |
) |
Net
cash provided by (used in) operating activities
|
|
|
23 |
|
|
|
(219 |
) |
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Repayment
of related party notes receivable
|
|
|
80 |
|
|
|
-
- |
|
Advances
under related party loan agreements
|
|
|
-
- |
|
|
|
(500 |
) |
Expenditures
for property, plant and equipment
|
|
|
(6 |
) |
|
|
(6 |
) |
Payments
to discontinued operations
|
|
|
-
- |
|
|
|
(104 |
) |
Distributions
from affiliates in excess of earnings
|
|
|
-
- |
|
|
|
24 |
|
Proceeds
from sales of assets
|
|
|
16 |
|
|
|
-
- |
|
Other
|
|
|
-
- |
|
|
|
3 |
|
Net
cash provided by (used in) investing activities – continuing
operations
|
|
|
90 |
|
|
|
(583 |
) |
Net
proceeds from sale of discontinued operations before
required repayment of debt
|
|
|
-
- |
|
|
|
1,089 |
|
Other
net cash provided by investing activities – discontinued
operations
|
|
|
-
- |
|
|
|
89 |
|
Net
cash provided by investing activities
|
|
|
90 |
|
|
|
595 |
|
See Notes
to the Consolidated Financial Statements.
MILLENNIUM
CHEMICALS INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS – (Continued)
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the six months ended
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
Repayment
of long-term debt
|
|
|
(158 |
) |
|
|
(390 |
) |
Proceeds
from related party notes payable
|
|
|
25 |
|
|
|
-
- |
|
Other
|
|
|
(2 |
) |
|
|
1 |
|
Net
cash used in financing activities – continuing operations
|
|
|
(135 |
) |
|
|
(389 |
) |
Debt
required to be repaid upon sale of discontinued operations
|
|
|
-
- |
|
|
|
(99 |
) |
Other
net cash provided by financing activities– discontinued
operations
|
|
|
-
- |
|
|
|
23 |
|
Net
cash used in financing activities
|
|
|
(135 |
) |
|
|
(465 |
) |
Effect
of exchange rate changes on cash
|
|
|
-
- |
|
|
|
1 |
|
Decrease
in cash and cash equivalents
|
|
|
(22 |
) |
|
|
(88 |
) |
Cash
and cash equivalents at beginning of period
|
|
|
51 |
|
|
|
121 |
|
Cash
and cash equivalents at end of period
|
|
$ |
29 |
|
|
$ |
33 |
|
See Notes
to the Consolidated Financial Statements.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
1.
|
|
7
|
2.
|
|
8
|
3.
|
|
10
|
4.
|
|
10
|
5.
|
|
11
|
6.
|
|
12
|
7.
|
|
14
|
8.
|
|
14
|
9.
|
|
14
|
10.
|
|
14
|
11.
|
|
15
|
12.
|
|
17
|
13.
|
|
17
|
14.
|
|
21
|
15.
|
|
21
|
16.
|
|
23
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The
accompanying consolidated financial statements are unaudited and have been
prepared from the books and records of Millennium Chemicals Inc. and its
subsidiaries (collectively, “Millennium”) in accordance with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X for interim financial
information. Accordingly, they do not include all of the information
and notes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments,
consisting only of normal recurring adjustments, considered necessary for a fair
presentation have been included. For further information, refer to
the audited consolidated financial statements and notes thereto included in the
Millennium Annual Report on Form 10-K for the year ended December 31,
2007. Certain previously reported amounts have been reclassified to
conform to current period presentation.
On
November 30, 2004, Lyondell Chemical Company (together with its consolidated
subsidiaries “Lyondell”) acquired Millennium in a stock-for-stock business
combination. As a result of the business combination, Millennium is a
wholly owned subsidiary of Lyondell.
On May
15, 2007, Millennium completed the sale of its worldwide inorganic chemicals
business in a transaction valued at approximately $1.3 billion, including
the acquisition of working capital and assumption of certain liabilities related
directly to the business (see Note 4).
On
December 20, 2007, LyondellBasell Industries AF S.C.A. (formerly known as
Basell AF S.C.A.) indirectly acquired all of the shares of Lyondell common
stock. As a result, Lyondell and Millennium both became indirect,
wholly owned subsidiaries of LyondellBasell Industries AF S.C.A. (together with
its consolidated subsidiaries, “LyondellBasell Industries” and without Lyondell,
the “Basell Group”).
Prior to
the December 20, 2007 acquisition of Lyondell by LyondellBasell Industries,
Millennium owned 29.5% of Equistar Chemicals, LP (“Equistar”), which is a joint
venture with Lyondell. As part of the acquisition, Lyondell made a
contribution to Equistar of $1,703 million (see Note 6), resulting in a decrease
in Millennium’s ownership interest to 21%.
As a
result of the acquisition of Lyondell by LyondellBasell Industries on December
20, 2007, Millennium’s assets and liabilities were revalued to reflect the
values assigned in LyondellBasell Industries’ accounting for the purchase of
Lyondell, resulting in a new basis of accounting. In addition,
Millennium has recognized in its financial statements $316 million of debt
at June 30, 2008 for which it is not the primary obligor, but which it has
guaranteed, and which was used by LyondellBasell Industries in the acquisition
of Lyondell, and the effects of its share of debt similarly guaranteed by
Equistar (collectively, “push-down debt”) through a reduction to zero of the
carrying value of its investment in Equistar.
In Staff
Accounting Bulletin (“SAB”), Topic 5J, Push Down Basis of Accounting
Required in Certain Limited Circumstances, the Securities and Exchange
Commission requires, among other things, that, in situations where debt is used
to acquire substantially all of an acquiree’s common stock and the acquiree
guarantees the debt or pledges its assets as collateral for the debt, the debt
and related interest expense and debt issuance costs be reflected in, or “pushed
down” to, the acquiree’s financial statements.
Although
this presentation may not reflect the likely future demands on Millennium
resources for servicing the debt of LyondellBasell Industries, it provides an
indication of that financial position after considering the maximum possible
demand on Millennium resources relating to the debt incurred by LyondellBasell
Industries in its acquisition of Lyondell. To facilitate an
understanding of the impact on these consolidated financial statements, the
effects of push-down debt are segregated.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
1. Basis
of Preparation – (Continued)
Millennium's
carrying value of push-down debt could be adjusted based on changes in its
consolidated net tangible assets, which impact the amount of Millennium's
guarantees, or by repayment of substantially all of the associated debt by
affiliates or by Millennium on an affiliate's behalf. Any adjustment to
the carrying value of push-down debt would result in a corresponding adjustment
to paid in capital.
Millennium's
investment in Equistar will continue to be carried at zero net value and no net
equity earnings or losses will be recognized until such time as Equistar incurs
positive partners’ capital, which may occur as a result of the repayment of
push-down debt by Equistar or its affiliates.
The
consolidated statements of income for the three and six months ended
June 30, 2008 reflect post-acquisition depreciation and amortization
expense based on the new value of the related assets and interest expense that
resulted from the debt used to finance the acquisition; therefore, the financial
information for the periods prior to and subsequent to the acquisition on
December 20, 2007 is not generally comparable. To indicate the
application of a different basis of accounting for the period subsequent to the
acquisition, periods prior to the acquisition are designated “predecessor”
periods, and those subsequent to the acquisition are designated “successor”
periods.
2. Accounting
and Reporting Changes
On April 25, 2008, the Financial
Accounting Standards Board (“FASB”) issued FASB Staff Position (“FSP”)
FAS 142-3, Determination of
the Useful Life of Intangible Assets. This FSP amends the factors that should be
considered in developing renewal or extension assumptions used to determine the
useful life of a recognized intangible asset under FASB Statement No. 142,
Goodwill and Other
Intangible Assets in order
to improve the consistency between the useful life of a recognized intangible
asset under Statement No. 142 and the period of expected cash flows used to
measure the fair value of the asset under FASB Statement No. 141 (Revised 2007),
Business
Combinations, and other
U.S. generally accepted accounting principles. This FSP is effective for
Millennium beginning in 2009. Early adoption is
prohibited. Millennium does not expect the application of
FSP 142-3 to have a material effect on its consolidated financial
statements.
In March
2008, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No.
161, Disclosures about
Derivatives Instruments and Hedging Activities, which amends and expands
the disclosure requirements of SFAS 133, Accounting for Derivative
Instruments and Hedging Activities, by requiring qualitative disclosures
about objectives and strategies for using derivatives, quantitative disclosures
about fair value amounts of and gains and losses on derivative instruments, and
disclosures about credit-risk-related contingent features in derivative
agreements. SFAS No. 161 will be effective for Millennium beginning
in 2009. Millennium is currently evaluating the effect of SFAS No.
161 on its disclosures.
In
December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in
Consolidated Financial Statements – an amendment to ARB No. 51, which
establishes new accounting and disclosure requirements for noncontrolling, or
minority, interests, including their classification as a separate component of
equity and the adjustment of net income to include amounts attributable to
minority interests. SFAS No. 160 also establishes new accounting
standards requiring recognition of a gain or loss upon deconsolidation of a
subsidiary. SFAS No. 160 will be effective for Millennium beginning
in 2009, with earlier application prohibited.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
2. Accounting and Reporting
Changes –
(Continued)
Also in
December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations, which
requires an acquiring entity to recognize all assets acquired and liabilities
assumed in a transaction at the acquisition date at fair value with limited
exceptions. SFAS No. 141 (revised 2007) will change the accounting
treatment for certain specific items, including: expensing of most acquisition
and restructuring costs; recording acquired contingent liabilities, in-process
research and development and noncontrolling, or minority, interests at fair
value; and recognizing changes in income tax valuations and uncertainties after
the acquisition date as income tax expense. SFAS No. 141 (revised
2007) also includes new disclosure requirements. For Millennium, SFAS
No. 141 (revised 2007) will apply to business combinations with acquisition
dates beginning in 2009. Earlier adoption is prohibited.
Although
certain past transactions, including the acquisition of Lyondell by
LyondellBasell Industries, would have been accounted for differently under SFAS
No. 160 and SFAS No. 141 (revised 2007), application of these statements in 2009
will not affect historical amounts.
SFAS No.
159, The Fair Value Option for
Financial Assets and Financial Liabilities – Including an amendment of FASB
Statement No. 115, which permits election of fair value to measure many
financial instruments and certain other items, was applicable to
Millennium effective January 1, 2008. Millennium has
elected not to apply the fair value option to any assets or
liabilities.
In
September 2006, the FASB issued SFAS No. 157, Fair Value
Measurements. The new standard defines fair value, establishes
a framework for its measurement and expands disclosures about such
measurements. In February 2008, the FASB issued FASB Staff Position
FAS 157-2, delaying the effective date of SFAS No. 157 for certain
nonfinancial assets and liabilities until January 1, 2009. Millennium
is currently evaluating the effect to its consolidated financial statements of
prospectively applying the provisions of SFAS No. 157 to those assets and
liabilities.
Implementation
of the provisions of SFAS No. 157 to financial assets and liabilities
beginning January 1, 2008 did not have a material effect on Millennium’s
consolidated financial statements.
Millennium
adopted the provisions of FASB Interpretation (“FIN”) No. 48, Accounting for Uncertainty in Income
Taxes, on
January 1, 2007. As a result of
the implementation of FIN No. 48, Millennium recognized a $47 million
increase in the liability related to uncertain income tax positions, a
$4 million increase in deferred tax assets and a $43 million increase
of the January 1, 2007 balance of retained deficit.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
3. Acquisition
of Lyondell by LyondellBasell Industries
On
December 20, 2007, LyondellBasell Industries indirectly acquired the outstanding
common shares of Lyondell and, as a result, Lyondell and Millennium became
indirect wholly owned subsidiaries of LyondellBasell Industries.
From
December 20, 2007, Millennium’s consolidated financial statements reflect a
revaluation of Millennium’s assets and liabilities, to reflect the allocation of
$1,312 million of the purchase price to Millennium assigned in
LyondellBasell Industries’ accounting for the purchase of
Lyondell. In addition, at June 30, 2008, Millennium recognized
in its financial statements $316 million of push-down debt for which it is
not the primary obligor, but which it has guaranteed, and which was used by
LyondellBasell Industries in the acquisition of Lyondell, and the effects of its
share of debt similarly guaranteed by Equistar through a reduction to zero of
the carrying value of its investment in Equistar. Millennium’s pro
rata share of Equistar’s push-down debt exceeded its investment in Equistar at
December 20, 2007; therefore, Millennium reduced to zero its investment in
Equistar and also, Millennium recorded push-down debt to the extent
allowed.
The
purchase price allocations used in the preparation of the June 30, 2008 and
December 31, 2007 financial statements are preliminary due to the
continuing analyses relating to the determination of the fair values of the
assets acquired and liabilities assumed. Any change to the fair value
of assets and liabilities acquired, based on information as of the acquisition
date, would result in a corresponding adjustment to
goodwill. Management does not expect the finalization of these
matters to have a material effect on the allocation.
Additional
paid in capital was $1,752 million and $1,745 million as of
June 30, 2008 and December 31, 2007, respectively. The
$7 million increase was due to purchase price allocation adjustments
affecting Millennium related to the acquisition by LyondellBasell Industries AF
S.C.A.
4. Discontinued
Operations
On May
15, 2007, Millennium completed the sale of the worldwide inorganic chemical
business in a transaction valued at approximately $1.3 billion, including
the acquisition of working capital and assumption of certain liabilities
directly related to the business.
The
operations of the inorganic chemicals business have been classified as
discontinued operations in the consolidated statements of income and cash
flows.
The
following represent the elements of cash flow for the six-month predecessor
period ended June 30, 2007 related to the sale of the inorganic chemicals
business:
Millions of
dollars
|
|
|
|
Gross
sales proceeds
|
|
$ |
1,143 |
|
Cash
and cash equivalents sold
|
|
|
(37 |
) |
Costs
related to the sale
|
|
|
(17 |
) |
Net
proceeds from sale of discontinued operations
before
required repayment of debt
|
|
|
1,089 |
|
Debt
required to be repaid
|
|
|
(99 |
) |
Net
proceeds from sale of discontinued operations
|
|
$ |
990 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
4. Discontinued
Operations – (Continued)
Amounts
included in income from discontinued operations are summarized as
follows:
|
|
Predecessor
|
|
|
Predecessor
|
|
|
|
For
the three months ended June 30, 2007
|
|
|
For
the six months ended June 30, 2007
|
|
Millions of
dollars
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$ |
181 |
|
|
$ |
514 |
|
Gain
on sale of discontinued operations
|
|
$ |
337 |
|
|
$ |
337 |
|
Income
(loss) from discontinued operations
|
|
|
(2 |
) |
|
|
18 |
|
Provision
for income taxes
|
|
|
52 |
|
|
|
58 |
|
Income
from discontinued operations, net of tax
|
|
$ |
283 |
|
|
$ |
297 |
|
The
provision for income taxes in the three months and six months ended
June 30, 2007 primarily reflects the effect of a higher tax basis in the
stock of a subsidiary included in the sale, which resulted in a lower taxable
gain. Income taxes payable related to the sale were $48
million.
5. Related
Party Transactions
Notes Payable to Lyondell Chemical
Company—Effective December 2007, a subsidiary of Millennium and a
subsidiary of Lyondell entered into two loan agreements. Under one of
the loan agreements, Millennium’s subsidiary may borrow from and, under the
other loan agreement, Millennium’s subsidiary may make advances to, the Lyondell
subsidiary for amounts up to and not exceeding
$2,000 million. The loans, which bear interest at London
Interbank Offered Rate (“LIBOR”) plus 4%, mature in 2012. Accrued
interest may, at the option of the parties, be added to the outstanding
principal amount of the note. At June 30, 2008, Millennium’s
subsidiary had a note payable of $25 million and at December 31, 2007,
these loans were not utilized. It is anticipated that Millennium and
Lyondell will replace the loan agreements with a current account agreement for
an indefinite period, under which Millennium may deposit excess cash balances
with the Lyondell subsidiary and have access to uncommitted revolving lines of
credit in excess of deposits.
Notes Receivable from
Equistar—In 2007, Millennium and Equistar entered into loan agreements
permitting Equistar to borrow up to $600 million from Millennium. In
connection with the acquisition of Lyondell by LyondellBasell Industries (see
Note 3), the maturity of the notes was extended to February 16, 2008 from
December 21, 2007, or earlier upon demand. The notes bore
interest, which was due quarterly, at the London Interbank Offered Rate LIBOR
plus 1.75%. The balance of the notes outstanding at December 31, 2007
of $80 million was collected in January 2008.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Prior to
December 20, 2007, Equistar was owned 70.5% by Lyondell and 29.5% by
Millennium. As part of the December 20, 2007 acquisition of Lyondell
by LyondellBasell Industries, Lyondell made a contribution to Equistar of $1,703
million, which was used to repay certain Equistar debt, resulting in an increase
of Lyondell’s direct ownership interest to 79% and a corresponding decrease in
Millennium’s ownership interest to 21%. As a result of Lyondell’s
November 30, 2004 acquisition of Millennium, Millennium and Equistar are wholly
owned subsidiaries of Lyondell. Millennium accounts for its
investment in Equistar using the equity method. As a partnership,
Equistar is not subject to federal income taxes.
As a
result of the acquisition of Lyondell by LyondellBasell Industries on December
20, 2007, Equistar’s assets and liabilities were revalued to reflect the values
assigned in LyondellBasell Industries’ accounting for the purchase of Lyondell,
resulting in a new basis of accounting. In addition, Equistar has
recognized in its financial statements $17,648 million of debt at
June 30, 2008 for which it is not the primary obligor but which it has
guaranteed, and which was used by LyondellBasell Industries in the acquisition
of Lyondell, and $251 million of related unamortized debt issuance costs at
June 30, 2008.
Millennium’s
pro rata share of Equistar’s push down debt exceeded the carrying value of its
investment in Equistar at December 20, 2007; therefore, Millennium reduced
to zero the carrying value of its investment.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
6. Investment
in Equistar Chemicals, LP – (Continued)
Summarized
financial information for Equistar follows:
Millions of
dollars
|
|
June
30,
|
|
|
December 31,
|
|
BALANCE
SHEETS
|
|
2008
|
|
|
2007
|
|
Total
current assets
|
|
$ |
1,971 |
|
|
$ |
2,012 |
|
Notes
receivable-related party
|
|
|
685 |
|
|
|
785 |
|
Property,
plant and equipment, net
|
|
|
5,170 |
|
|
|
5,116 |
|
Goodwill
|
|
|
639 |
|
|
|
750 |
|
Debt
issuance costs on push-down debt
|
|
|
251 |
|
|
|
334 |
|
Investments
and other assets, net
|
|
|
900 |
|
|
|
1,075 |
|
Total
assets
|
|
$ |
9,616 |
|
|
$ |
10,072 |
|
Current
maturities of long-term debt:
|
|
|
|
|
|
|
|
|
Push-down
debt
|
|
$ |
144 |
|
|
$ |
146 |
|
Debt
of Equistar
|
|
|
-
- |
|
|
|
27 |
|
Related
party borrowings:
|
|
|
|
|
|
|
|
|
Notes
payable
|
|
|
200 |
|
|
|
80 |
|
Push-down
debt
|
|
|
740 |
|
|
|
717 |
|
Other
current liabilities
|
|
|
1,447 |
|
|
|
1,461 |
|
Long-term
debt:
|
|
|
|
|
|
|
|
|
Push
down debt
|
|
|
16,764 |
|
|
|
16,829 |
|
Debt
of Equistar
|
|
|
130 |
|
|
|
129 |
|
Other
liabilities and deferred revenues
|
|
|
297 |
|
|
|
295 |
|
Partners’
deficit
|
|
|
(10,106 |
) |
|
|
(9,612 |
) |
Total
liabilities and partners’ deficit
|
|
$ |
9,616 |
|
|
$ |
10,072 |
|
|
|
|
|
|
Predecessor
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the three months ended
June
30,
|
|
|
For
the six months ended
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
STATEMENTS
OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$ |
4,136 |
|
|
$ |
3,534 |
|
|
$ |
7,957 |
|
|
$ |
6,403 |
|
Cost
of sales
|
|
|
4,362 |
|
|
|
3,362 |
|
|
|
8,269 |
|
|
|
6,100 |
|
Selling,
general and administrative expenses
|
|
|
59 |
|
|
|
72 |
|
|
|
129 |
|
|
|
131 |
|
Research
and development expenses
|
|
|
8 |
|
|
|
9 |
|
|
|
16 |
|
|
|
18 |
|
Operating
income (loss)
|
|
|
(293 |
) |
|
|
91 |
|
|
|
(457 |
) |
|
|
154 |
|
Interest
expense, net
|
|
|
(372 |
) |
|
|
(50 |
) |
|
|
(753 |
) |
|
|
(103 |
) |
Other
expense, net
|
|
|
-
- |
|
|
|
(33 |
) |
|
|
(2 |
) |
|
|
(32 |
) |
Net
income (loss)
|
|
$ |
(665 |
) |
|
$ |
8 |
|
|
$ |
(1,212 |
) |
|
$ |
19 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Millennium
had trade accounts receivable balances of $104 million and
$106 million as of June 30, 2008 and December 31, 2007,
respectively. These balances were net of an allowance for doubtful
accounts of $1 million at June 30, 2008 and December 31, 2007,
respectively.
Inventories
consisted of the following components:
|
|
June
30,
|
|
|
December
31,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
Finished
goods
|
|
$ |
93 |
|
|
$ |
65 |
|
Work-in-process
|
|
|
21 |
|
|
|
21 |
|
Raw
materials
|
|
|
4 |
|
|
|
3 |
|
Materials
and supplies
|
|
|
13 |
|
|
|
15 |
|
Total
inventories
|
|
$ |
131 |
|
|
$ |
104 |
|
9. Property,
Plant and Equipment, Net
The
components of property, plant and equipment, at cost, and the related
accumulated depreciation were as follows:
|
|
June
30,
|
|
|
December
31,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
Land
|
|
$ |
11 |
|
|
$ |
11 |
|
Manufacturing
facilities and equipment
|
|
|
295 |
|
|
|
277 |
|
Construction
in progress
|
|
|
26 |
|
|
|
23 |
|
Total
property, plant and equipment
|
|
|
332 |
|
|
|
311 |
|
Less
accumulated depreciation
|
|
|
(20 |
) |
|
|
(1 |
) |
Property,
plant and equipment, net
|
|
$ |
312 |
|
|
$ |
310 |
|
Depreciation
and amortization expense is summarized as follows:
|
|
Successor
|
|
|
Predecessor
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the three months ended
June
30,
|
|
|
For
the six months ended
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Property,
plant and equipment
|
|
$ |
7 |
|
|
$ |
10 |
|
|
$ |
19 |
|
|
$ |
14 |
|
Other
|
|
|
5 |
|
|
|
1 |
|
|
|
7 |
|
|
|
3 |
|
Total
depreciation and amortization
|
|
$ |
12 |
|
|
$ |
11 |
|
|
$ |
26 |
|
|
$ |
17 |
|
Accounts
payable at June 30, 2008 and December 31, 2007 included liabilities in the
amounts of $2 million and $3 million, respectively, for checks issued
in excess of associated bank balances but not yet presented for
collection.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
As a
result of the December 20, 2007 acquisition of Lyondell by LyondellBasell
Industries, Millennium recorded $350 million of push down debt for which it
is not the primary obligor, but which it has guaranteed, and which was used by
LyondellBasell Industries in the acquisition of Lyondell (see Notes 1 and
3). The balance outstanding at June 30, 2008 related to
push-down debt was $316 million.
Long-term
debt under which Millennium is the primary obligor consisted of the
following:
Millions of
dollars
|
|
June
30,
2008
|
|
|
December
31,
2007
|
|
Senior
Debentures due 2026, 7.625% ($70 million of discount)
|
|
$ |
171 |
|
|
$ |
170 |
|
Convertible
Senior Debentures due 2023, 4%
|
|
|
-
- |
|
|
|
158 |
|
Total
|
|
|
171 |
|
|
|
328 |
|
Less
current maturities
|
|
|
-
- |
|
|
|
(158 |
) |
Total
long-term debt, net
|
|
$ |
171 |
|
|
$ |
170 |
|
Millennium
is a guarantor of certain debt borrowed by Lyondell under the LyondellBasell
Industries Senior Secured Credit Facility, including $1,465 million and
$7,512 million, respectively, under the term loan A and B facilities and
certain LyondellBasell Industries debt, including an $8,000 million Senior
Secured Interim loan, the Basell Group’s 8.375% High Yield Notes due 2015,
comprising borrowings of $615 million and €500 million ($789 million),
and amounts borrowed by the Basell Group under the Senior Secured Credit
Facility, consisting of $488 million borrowed under term loan A and
€1,294 million ($2,043 million) under term loan B as well as amounts
borrowed by Lyondell or the Basell Group under the $1,000 million revolving
credit facility under which there was no outstanding borrowing at June 30,
2008. Millennium is also a guarantor for amounts borrowed under the
Senior Secured Inventory-Based Credit Facility by Lyondell and a U.S.-based
subsidiary of the Basell Group. At June 30, 2008,
borrowings of $1,183 million were outstanding under the Senior Secured
Inventory-Based Credit Facility; $1,053 million on the part of Lyondell and
$130 million on the part of the Basell Group. Millennium may not
incur additional indebtedness in excess of 15% of Millennium’s Consolidated Net
Tangible Assets (“CNTA”), as defined in the indenture governing Millennium’s
7.625% Senior Debentures due 2026.
Debt Agreement
Amendments—Under
the terms of the financing for the Lyondell acquisition, the joint lead
arrangers (“JLAs”) retained the right to flex certain provisions of the
financing, including pricing and the reallocation and retranching of the Term
Loans. Effective April 30, 2008, the JLAs exercised the price flex
provisions and, in conjunction with the exercise, the Senior Secured Credit
Facility was amended to (i) convert each of the U.S. Tranche B Dollar Term Loan
and the German Tranche B Euro Term Loan into three separate tranches, some of
which tranches are subject to a prepayment penalty, (ii) increase interest rates
and fee rates by 0.5%, (iii) establish a LIBOR floor of 3.25% on the U.S.
Tranche B Dollar Term Loan, (iv) modify certain debt covenants,
including increasing a general debt basket from $750 million to
$1,000 million, eliminating an interest rate hedging requirement,
increasing the asset backed facility basket by $500 million, and adding a
covenant prohibiting reduction of aggregate commitments under the Revolving
Credit Facility with Access Industries before its initial maturity, (v) amend
the calculation of Consolidated EBITDA, as defined, for the purpose of
determining compliance with debt requirements, to reflect adjustments to present
2007 cost of sales in accordance with FIFO inventory accounting, and (vi) make
other changes, including technical and typographical corrections.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
11. Long-Term
Debt – (Continued)
In
conjunction with the exercise by the JLAs of their flex rights, additional
amendments were made to each of the Senior Secured Interim Loan, Senior Secured
Inventory-Based Credit Facility, Revolving Credit Facility with Access
Industries and Accounts Receivable Securitization Facility. The
amendments to the Senior Secured Interim Loan and Senior Secured Inventory-Based
Credit Facility and the Revolving Credit Facility with Access Industries were
effective on April 30, 2008. The amendments to the Accounts
Receivable Securitization Facility were effective on May 6, 2008.
Each of
the Senior Secured Interim Loan, the Senior Secured Inventory-Based Credit
Facility, the Accounts Receivable Securitization Facility and Revolving Credit
Facility with Access Industries were amended to (i) conform to certain of
the amendments to the Senior Secured Credit Facility and (ii) make other
changes, including technical and typographical corrections. In
addition, the Senior Secured Inventory-Based Credit Facility was amended to
allow Lyondell the future option to increase the aggregate amount of commitments
under the facility by a further $500 million.
Under the
terms of the Senior Secured Inventory-Based Credit Facility, as amended,
Lyondell could elect to increase commitments under the facility by up to an
aggregate $1,100 million. Effective April 30, 2008, Lyondell
exercised the option to increase the facility by $600 million and, as a
result, aggregate commitments under the facility increased from
$1,000 million to $1,600 million. Concurrent with the
exercise of the increase in commitments, Lyondell Chemical Company became a lien
grantor and added the following as collateral: (i) a first priority pledge of
all equity interests owned by Lyondell Chemical Company in, and all indebtedness
owed to it by, LyondellBasell Receivables I, LLC (the seller under the Accounts
Receivable Securitization Facility) and (ii) a first priority security interest
in all accounts receivable, inventory and related assets owned by Lyondell
Chemical Company, subject to customary exceptions.
Other—During the six months
ended June 30, 2008, Millennium repaid the $158 million of its 4%
Convertible Senior Debentures due 2023.
Amortization
of debt discounts and debt issuance costs resulted in expenses of less than
$1 million for each of the three month periods ended June 30, 2008 and
2007 and resulted in expenses of $2 million and less than $1 million
for each of the six month periods ended June 30, 2008 and 2007, which are
included in interest expense in the Consolidated Statements of
Income. Amounts related to push-down debt are included in “Interest
Expense on push-down debt” in the Consolidated Statements of Income for the
three and six months ended June 30, 2008.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
12. Pension
and Other Postretirement Benefits
Net
periodic pension benefits for continuing operations included the following cost
components:
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the three months ended
June
30,
|
|
|
For
the six months ended
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Service
cost
|
|
$ |
- - |
|
|
$ |
1 |
|
|
$ |
1 |
|
|
$ |
2 |
|
Interest
cost
|
|
|
8 |
|
|
|
8 |
|
|
|
16 |
|
|
|
16 |
|
Recognized
return on plan assets
|
|
|
(9 |
) |
|
|
(9 |
) |
|
|
(19 |
) |
|
|
(18 |
) |
Amortization
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
4 |
|
Net
periodic pension benefit cost (benefit)
|
|
$ |
(1 |
) |
|
$ |
1 |
|
|
$ |
(2 |
) |
|
$ |
4 |
|
Net
periodic other postretirement benefits costs were $1 million in each of the
three- and six-month periods ended June 30, 2008 and were net credits of less
than $1 million and $1 million, respectively, in the three- and
six-month periods ended June 30, 2007.
13. Commitments
and Contingencies
Environmental
Remediation—Millennium’s accrued liability for future environmental
remediation costs at current and former plant sites and other remediation sites
totaled $174 million and $181 million as of
June 30, 2008 and December 31, 2007, respectively. The
remediation expenditures are expected to occur over a number of years, and not
to be concentrated in any single year. In the opinion of management,
there is no material estimable range of reasonably possible loss in excess of
the liabilities recorded for environmental remediation. However, it
is possible that new information about the sites for which the accrual has been
established, new technology or future developments such as involvement in
investigations by regulatory agencies, could require Millennium to reassess its
potential exposure related to environmental matters.
The
following table summarizes the activity in Millennium’s accrued environmental
liability for the six months ended June 30:
|
|
Successor
|
|
|
Predecessor
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
Balance
at January 1
|
|
$ |
181 |
|
|
$ |
148 |
|
Adjustments
to purchase price allocation
|
|
|
2 |
|
|
|
-- |
|
Additional
accruals
|
|
|
-- |
|
|
|
10 |
|
Amounts
paid
|
|
|
(9 |
) |
|
|
(5 |
) |
Balance
at June 30
|
|
$ |
174 |
|
|
$ |
153 |
|
The
liabilities for individual sites range from less than $1 million to $140
million. The $140 million liability relates to the Kalamazoo River
Superfund Site.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
13. Commitments
and Contingencies – (Continued)
A
Millennium subsidiary has been identified as a Potential Responsible Party
(“PRP”) with respect to the Kalamazoo River Superfund Site. The site
involves cleanup of river sediments and floodplain soils contaminated with
polychlorinated biphenyls, cleanup of former paper mill operations, and cleanup
and closure of landfills associated with the former paper mill
operations.
In 2000,
the Kalamazoo River Study Group (the “KRSG”), of which the Millennium subsidiary
and other PRPs are members, submitted to the State of Michigan a Draft Remedial
Investigation and Draft Feasibility Study, which evaluated a number of remedial
options for the river. The estimated costs for these remedial options
ranged from $0 to $2.5 billion. Although the KRSG study identified a
broad range of remedial options, not all of those options would represent
reasonably possible outcomes. Management does not believe that it can
identify a single remedy among those options that would represent the
highest-cost reasonably possible outcome.
In 2004,
Millennium recognized a liability representing the Millennium subsidiary’s
interim allocation of 55% of the $73 million total of estimated cost of
riverbank stabilization, recommended as the preferred remedy in 2000 by the KRSG
study, and of certain other costs.
At the
end of 2001, the U.S. Environmental Protection Agency (“EPA”) took lead
responsibility for the river portion of the site at the request of the State of
Michigan. In 2004, the EPA initiated a confidential process to
facilitate discussions among the agency, the Millennium subsidiary, other PRPs,
the Michigan Departments of Environmental Quality and Natural Resources, and
certain federal natural resource trustees about the need for additional
investigation activities and different possible approaches for addressing the
contamination in and along the Kalamazoo River. As these discussions
have continued, management has obtained new information about regulatory
oversight costs and other remediation costs, including a proposed remedy to be
applied to a specific portion of the river, and has been able to reasonably
estimate anticipated costs for certain other segments of the river, based in
part on experience to date with the remedy currently being applied to the one
portion of the river. As a result, management can reasonably estimate
the probable spending for remediation of three segments of the river, which has
been accrued as of June 30, 2008. Management’s best estimates
for costs relating to other segments of the river, which may remain uncertain
for the foreseeable future, also have been accrued based on the KRSG
study.
As of
June 30, 2008, the probable additional future remediation spending
associated with the river cannot be determined with certainty but the amounts
accrued are believed to be the current best estimate of future costs, based on
information currently available. At June 30, 2008, the balance
of the liability related to the river was $95 million.
In
addition, Millennium has recognized a liability primarily related to
Millennium’s estimated share of remediation costs for two former paper mill
sites and associated landfills, which are also part of the Kalamazoo River
Superfund Site. At June 30, 2008, the balance of the liability
was $45 million. Although no final agreement has been reached as
to the ultimate remedy for these locations, Millennium has begun remediation
activity related to these sites.
Millennium’s
ultimate liability for the Kalamazoo River Superfund Site will depend on many
factors that have not yet been determined, including the ultimate remedies
selected, the determination of natural resource damages, the number and
financial viability of the other PRPs, and the determination of the final
allocation among the PRPs.
The
balance, at June 30, 2008, of remediation liabilities related to Millennium
sites other than the Kalamazoo River Superfund Site was
$34 million.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
13. Commitments
and Contingencies – (Continued)
Litigation—Together with
alleged past manufacturers of lead-based paint and lead pigments for use in
paint, Millennium has been named as a defendant in various legal proceedings
alleging personal injury, property damage, and remediation costs allegedly
associated with the use of these products. The majority of these
legal proceedings assert unspecified monetary damages in excess of the statutory
minimum and, in certain cases, seek equitable relief such as abatement of
lead-based paint in buildings. Legal proceedings relating to lead
pigment or paint are in various trial stages and post-dismissal settings, some
of which are on appeal.
One legal
proceeding relating to lead pigment or paint was tried in 2002. On
October 29, 2002, the judge in that case declared a mistrial after the jury
declared itself deadlocked. The sole issue before the jury was
whether lead pigment in paint in and on Rhode Island buildings constituted a
“public nuisance.” The re-trial of this case began on November 1,
2005. On February 22, 2006, a jury returned a verdict in favor of the
State of Rhode Island finding that the cumulative presence of lead pigments in
paints and coatings on buildings in the state constitutes a public nuisance;
that a Millennium subsidiary, Millennium Holdings, LLC, and other defendants
either caused or substantially contributed to the creation of the public
nuisance; and that those defendants, including the Millennium subsidiary, should
be ordered to abate the public nuisance. On February 28, 2006, the
judge held that the state could not proceed with its claim for punitive
damages. On February 26, 2007, the court issued its decision denying
the post-verdict motions of the defendants, including the Millennium subsidiary,
for a mistrial or a new trial. The court concluded that it would
enter an order of abatement and appoint a special master to assist the court in
determining the scope of the abatement remedy. On March 16,
2007, the court entered a final judgment on the jury’s verdict. On
March 20, 2007, the Millennium subsidiary and the other defendants
filed a notice of appeal with the Rhode Island Supreme Court. On
December 18, 2007, the trial court appointed two special masters to serve as
“examiners” and to assist the trial court in the proposed abatement
proceedings. On May 15, 2008, the Rhode Island Supreme Court
heard oral argument on, among other things, Millennium’s appeal of the jury’s
verdict in favor of the State of Rhode Island. On July 1, 2008,
the Rhode Island Supreme Court unanimously reversed the jury’s verdict and
subsequent judgment against Millennium and the other defendants. The
Rhode Island Supreme Court’s verdict effectively ends this legal
proceeding.
Millennium’s
defense costs to date for lead-based paint and lead pigment litigation largely
have been covered by insurance. Millennium has insurance policies
that potentially provide approximately $1 billion in indemnity coverage for
lead-based paint and lead pigment litigation. Millennium’s ability to
collect under the indemnity coverage would depend upon, among other things, the
resolution of certain potential coverage defenses that the insurers are likely
to assert and the solvency of the various insurance carriers that are part of
the coverage block at the time of such a request.
While
Millennium believes that it has valid defenses to all the lead-based paint and
lead pigment proceedings and is vigorously defending them, litigation is
inherently subject to many uncertainties. Any liability that
Millennium may ultimately incur, net of any insurance or other recoveries,
cannot be estimated at this time.
Guarantees—In addition to
debt guarantees disclosed in Note 11, Millennium continues to guarantee certain
obligations related to the sold inorganic chemicals business until such time as
the buyer completes certain procedures to replace Millennium as
guarantor. The guarantees, principally with respect to the lease of
research facilities, have a total potential obligation of approximately
$35 million over their remaining term. Millennium does not
expect that any payments will be required under these guarantees.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
13. Commitments
and Contingencies – (Continued)
Indemnification—Millennium
and its joint ventures are parties to various indemnification arrangements,
including arrangements entered into in connection with acquisitions,
divestitures and the formation of joint ventures. For example,
Millennium entered into indemnification arrangements in connection with its
demerger from Hanson plc, and Equistar and its owner companies (including
Millennium) entered into indemnification arrangements in connection with the
formation of Equistar. Pursuant to these arrangements, Millennium and
its joint ventures provide indemnification to and/or receive indemnification
from other parties in connection with liabilities that may arise in connection
with the transactions and in connection with activities prior to completion of
the transactions. These indemnification arrangements typically
include provisions pertaining to third party claims relating to environmental
and tax matters and various types of litigation. As of June 30, 2008,
Millennium has not accrued any significant amounts for such indemnification
obligations. Millennium cannot determine with certainty the potential
amount of future payments under the indemnification arrangements until events
arise that would trigger a liability under the arrangements.
Other—Millennium and its
joint ventures are, from time to time, defendants in lawsuits and other
commercial disputes, some of which are not covered by insurance. Many
of these suits make no specific claim for relief. Although final
determination of any liability and resulting financial impact with respect to
any such matters cannot be ascertained with any degree of certainty, management
does not believe that any ultimate uninsured liability resulting from these
matters in which it, its subsidiaries or its joint ventures currently are
involved will, individually or in the aggregate, have a material adverse effect
on the financial position, liquidity or results of operations of
Millennium.
General—In the opinion of
management, the matters discussed in this note, other than potential future
liabilities for environmental remediation which amounts cannot be estimated, are
not expected to have a material adverse effect on the financial position or
liquidity of Millennium. However, the adverse resolution in any
reporting period of one or more of the matters discussed in this note could have
a material impact on Millennium’s results of operations for that period, which
may be mitigated by contribution or indemnification obligations of others, or by
any insurance coverage that may be available.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The
components of comprehensive income were as follows:
|
|
Successor
|
|
|
Predecessor
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the three months ended
June
30,
|
|
|
For
the six months ended
June
30,
|
|
Millions of
dollars
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Net
income
|
|
$ |
3 |
|
|
$ |
266 |
|
|
$ |
20 |
|
|
$ |
281 |
|
Other
comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization
of actuarial and investment loss
included
in net periodic pension cost
|
|
|
-
- |
|
|
|
3 |
|
|
|
-
- |
|
|
|
3 |
|
Discontinued
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
currency translation
|
|
|
-
- |
|
|
|
7 |
|
|
|
-
- |
|
|
|
16 |
|
Amortization
of actuarial and investment loss
included
in net periodic pension cost
|
|
|
-
- |
|
|
|
2 |
|
|
|
-
- |
|
|
|
2 |
|
Sale
of discontinued operations
|
|
|
-
- |
|
|
|
(63 |
) |
|
|
-
- |
|
|
|
(63 |
) |
Total
other comprehensive loss
|
|
|
-
- |
|
|
|
(51 |
) |
|
|
-
- |
|
|
|
(42 |
) |
Comprehensive
income
|
|
$ |
3 |
|
|
$ |
215 |
|
|
$ |
20 |
|
|
$ |
239 |
|
15. Segment
and Related Information
At the
time of the acquisition of Lyondell by LyondellBasell Industries, LyondellBasell
Industries established new business segments through which Millennium’s
operations are managed.
Millennium,
a wholly owned subsidiary of Lyondell, operates in one reportable
segment. Millennium’s chemicals business segment produces and
markets: acetyls, which include VAM, acetic acid and methanol; and
fragrance and flavors chemicals.
On May
15, 2007, Millennium completed the sale of its worldwide inorganic chemicals
business (see Note 4) and substantially all of the inorganic chemicals segment
was reclassified as a discontinued operation.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
15. Segment
and Related Information – (Continued)
Summarized
financial information concerning reportable segments is shown in the following
table for the periods presented:
Millions of
dollars
|
|
Chemicals
|
|
|
Other
|
|
|
Total
|
|
Successor
|
|
|
|
|
|
|
|
|
|
For the three months
ended June 30, 2008
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$ |
193 |
|
|
$ |
- - |
|
|
$ |
193 |
|
Operating
income (loss)
|
|
|
23 |
|
|
|
(4 |
) |
|
|
19 |
|
Loss
from equity investment
|
|
|
(62 |
) |
|
|
-
- |
|
|
|
(62 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$ |
159 |
|
|
$ |
2 |
|
|
$ |
161 |
|
Operating
income (loss)
|
|
|
17 |
|
|
|
(21 |
) |
|
|
(4 |
) |
Income
from equity investment
|
|
|
3 |
|
|
|
-
- |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months
ended June 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$ |
399 |
|
|
$ |
- - |
|
|
$ |
399 |
|
Operating
income (loss)
|
|
|
65 |
|
|
|
(8 |
) |
|
|
57 |
|
Loss
from equity investment
|
|
|
(96 |
) |
|
|
-
- |
|
|
|
(96 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months
ended June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$ |
309 |
|
|
$ |
4 |
|
|
$ |
313 |
|
Operating
income (loss)
|
|
|
41 |
|
|
|
(28 |
) |
|
|
13 |
|
Income
from equity investment
|
|
|
6 |
|
|
|
-
- |
|
|
|
6 |
|
Operating
income (loss) in the “Other” column above included a business that was not a
reportable segment and costs not allocated to Millennium’s chemicals segment,
including costs from predecessor businesses.
The 2007
segment information presented above has been reclassified to conform with the
new business segment created during the acquisition of Lyondell by
LyondellBasell Industries.
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
16. Supplemental
Guarantor Information
Millennium
America Inc. (“Millennium America”), a 100% owned indirect subsidiary of
Millennium, is a holding company for all of Millennium’s continuing and, prior
to May 15, 2007, discontinued operating subsidiaries other than its discontinued
operations in the United Kingdom, France, Brazil and
Australia. Millennium America is the issuer of the 7.625% Senior
Debentures. Millennium was the issuer of the 4% Convertible Senior
Debentures, which were completely repaid during the first six months of
2008. Millennium America fully and unconditionally guaranteed all
obligations under the 4% Convertible Senior Debentures, while
outstanding. The 7.625% Senior Debentures are fully and
unconditionally guaranteed by Millennium. The following condensed
consolidating financial information presents supplemental information for
Millennium Chemicals Inc., the parent, and Millennium America as of June 30,
2008 and December 31, 2007 and for the three- and six-month periods ended
June 30, 2008 and 2007.
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
BALANCE
SHEET
|
|
As
of June 30, 2008
|
|
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Millions of
dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventories
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
131 |
|
|
$ |
- - |
|
|
$ |
131 |
|
Other
current assets
|
|
|
-
- |
|
|
|
-
- |
|
|
|
238 |
|
|
|
-
- |
|
|
|
238 |
|
Property,
plant and equipment, net
|
|
|
-
- |
|
|
|
-
- |
|
|
|
312 |
|
|
|
-
- |
|
|
|
312 |
|
Investment
in Equistar Chemicals, LP:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior
to push-down debt
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1,556 |
|
|
|
-
- |
|
|
|
1,556 |
|
Effect
of push-down debt
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(1,556 |
) |
|
|
-
- |
|
|
|
(1,556 |
) |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
Investment
in subsidiaries
|
|
|
111 |
|
|
|
374 |
|
|
|
16 |
|
|
|
(485 |
) |
|
|
16 |
|
Other
assets, net
|
|
|
2 |
|
|
|
-
- |
|
|
|
175 |
|
|
|
-
- |
|
|
|
177 |
|
Due
from parent and affiliates, net
|
|
|
-
- |
|
|
|
233 |
|
|
|
-
- |
|
|
|
(233 |
) |
|
|
-
- |
|
Total
assets
|
|
$ |
113 |
|
|
$ |
607 |
|
|
$ |
872 |
|
|
$ |
(718 |
) |
|
$ |
874 |
|
Notes
payable - related party
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
25 |
|
|
$ |
- - |
|
|
$ |
25 |
|
Other
current liabilities
|
|
|
-
- |
|
|
|
2 |
|
|
|
177 |
|
|
|
-
- |
|
|
|
179 |
|
Long-term
debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Push-down
debt
|
|
|
316 |
|
|
|
316 |
|
|
|
-
- |
|
|
|
(316 |
) |
|
|
316 |
|
Debt
of Millennium
|
|
|
-
- |
|
|
|
171 |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
171 |
|
Other
liabilities
|
|
|
-
- |
|
|
|
-
- |
|
|
|
228 |
|
|
|
-
- |
|
|
|
228 |
|
Deferred
income taxes
|
|
|
-
- |
|
|
|
-
- |
|
|
|
238 |
|
|
|
-
- |
|
|
|
238 |
|
Due
to parent and affiliates, net
|
|
|
87 |
|
|
|
-
- |
|
|
|
146 |
|
|
|
(233 |
) |
|
|
-
- |
|
Total
liabilities
|
|
|
403 |
|
|
|
489 |
|
|
|
814 |
|
|
|
(549 |
) |
|
|
1,157 |
|
Minority
interest
|
|
|
-
- |
|
|
|
-
- |
|
|
|
7 |
|
|
|
-
- |
|
|
|
7 |
|
Stockholder’s
equity (deficit)
|
|
|
(290 |
) |
|
|
118 |
|
|
|
51 |
|
|
|
(169 |
) |
|
|
(290 |
) |
Total
liabilities and Stockholder’s
equity
|
|
$ |
113 |
|
|
$ |
607 |
|
|
$ |
872 |
|
|
$ |
(718 |
) |
|
$ |
874 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
BALANCE
SHEET
|
|
As
of December 31, 2007
|
|
Millions of
dollars
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Inventories
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
104 |
|
|
$ |
- - |
|
|
$ |
104 |
|
Notes receivable -
related party |
|
|
80 |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
80 |
|
Other
current assets
|
|
|
3 |
|
|
|
24 |
|
|
|
229 |
|
|
|
-
- |
|
|
|
256 |
|
Property,
plant and equipment, net
|
|
|
-
- |
|
|
|
-
- |
|
|
|
310 |
|
|
|
-
- |
|
|
|
310 |
|
Investment
in Equistar Chemicals, LP:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior
to push-down debt
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1,652 |
|
|
|
-
- |
|
|
|
1,652 |
|
Effect
of push-down debt
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(1,652 |
) |
|
|
-
- |
|
|
|
(1,652 |
) |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
Investment
in subsidiaries
|
|
|
68 |
|
|
|
355 |
|
|
|
16 |
|
|
|
(423 |
) |
|
|
16 |
|
Other
assets, net
|
|
|
2 |
|
|
|
1 |
|
|
|
190 |
|
|
|
-
- |
|
|
|
193 |
|
Due
from parent and affiliates, net
|
|
|
-
- |
|
|
|
163 |
|
|
|
-
- |
|
|
|
(163 |
) |
|
|
-
- |
|
Total
assets
|
|
$ |
153 |
|
|
$ |
543 |
|
|
$ |
849 |
|
|
$ |
(586 |
) |
|
$ |
959 |
|
Current
maturities of long-term debt
|
|
$ |
44 |
|
|
$ |
- - |
|
|
$ |
114 |
|
|
$ |
- - |
|
|
$ |
158 |
|
Other
current liabilities
|
|
|
115 |
|
|
|
2 |
|
|
|
64 |
|
|
|
-
- |
|
|
|
181 |
|
Long-term
debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Push-down
debt
|
|
|
350 |
|
|
|
350 |
|
|
|
-
- |
|
|
|
(350 |
) |
|
|
350 |
|
Debt
of Millennium
|
|
|
-
- |
|
|
|
170 |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
170 |
|
Other
liabilities
|
|
|
-
- |
|
|
|
-
- |
|
|
|
238 |
|
|
|
-
- |
|
|
|
238 |
|
Deferred
income taxes
|
|
|
-
- |
|
|
|
-
- |
|
|
|
221 |
|
|
|
-
- |
|
|
|
221 |
|
Due
to parent and affiliates, net
|
|
|
10 |
|
|
|
-
- |
|
|
|
153 |
|
|
|
(163 |
) |
|
|
-
- |
|
Total
liabilities
|
|
|
519 |
|
|
|
522 |
|
|
|
790 |
|
|
|
(513 |
) |
|
|
1,318 |
|
Minority
interest
|
|
|
-
- |
|
|
|
-
- |
|
|
|
7 |
|
|
|
-
- |
|
|
|
7 |
|
Stockholder’s
equity (deficit)
|
|
|
(366 |
) |
|
|
21 |
|
|
|
52 |
|
|
|
(73 |
) |
|
|
(366 |
) |
Total
liabilities and stockholder’s equity
|
|
$ |
153 |
|
|
$ |
543 |
|
|
$ |
849 |
|
|
$ |
(586 |
) |
|
$ |
959 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF INCOME
|
|
Successor
|
|
For
the Three Months Ended June 30, 2008
|
|
Millions of
dollars
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Sales
and other operating revenues
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
193 |
|
|
$ |
- - |
|
|
$ |
193 |
|
Cost
of sales
|
|
|
-
- |
|
|
|
-
- |
|
|
|
164 |
|
|
|
-
- |
|
|
|
164 |
|
Selling,
general and administrative expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
10 |
|
|
|
-
- |
|
|
|
10 |
|
Operating
income
|
|
|
-
- |
|
|
|
-
- |
|
|
|
19 |
|
|
|
-- |
|
|
|
19 |
|
Interest
expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense on push-down debt
|
|
|
(8 |
) |
|
|
(8 |
) |
|
|
-
- |
|
|
|
8 |
|
|
|
(8 |
) |
Millennium
debt
|
|
|
-
- |
|
|
|
(6 |
) |
|
|
-
- |
|
|
|
-
- |
|
|
|
(6 |
) |
Interest
income (expense), net - related party
|
|
|
-
- |
|
|
|
27 |
|
|
|
(27 |
) |
|
|
-
- |
|
|
|
-
- |
|
Interest
income
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
1 |
|
Loss
from equity investment in Equistar
Chemicals, LP
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(62 |
) |
|
|
-
- |
|
|
|
(62 |
) |
Effect
of push-down debt on loss from equity investment in
Equistar
|
|
|
-
- |
|
|
|
-
- |
|
|
|
62 |
|
|
|
-
- |
|
|
|
62 |
|
Equity
in income of subsidiaries
|
|
|
13 |
|
|
|
39 |
|
|
|
-
- |
|
|
|
(52 |
) |
|
|
-
- |
|
Other
expense
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(1 |
) |
|
|
-
- |
|
|
|
(1 |
) |
Benefit
from (provision for) income taxes
|
|
|
(2 |
) |
|
|
(1 |
) |
|
|
1 |
|
|
|
-
- |
|
|
|
(2 |
) |
Net
income (loss)
|
|
$ |
3 |
|
|
$ |
51 |
|
|
$ |
(7 |
) |
|
$ |
(44 |
) |
|
$ |
3 |
|
STATEMENT
OF INCOME
|
|
Predecessor
|
|
For
the Three Months Ended June 30, 2007
|
|
Millions of
dollars
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Sales
and other operating revenues
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
161 |
|
|
$ |
- - |
|
|
$ |
161 |
|
Cost
of sales
|
|
|
-
- |
|
|
|
-
- |
|
|
|
142 |
|
|
|
-
- |
|
|
|
142 |
|
Selling,
general and administrative expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
22 |
|
|
|
-
- |
|
|
|
22 |
|
Research
and development expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
1 |
|
Operating
loss
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(4 |
) |
|
|
-
- |
|
|
|
(4 |
) |
Interest
expense, net
|
|
|
-
- |
|
|
|
(10 |
) |
|
|
(3 |
) |
|
|
-
- |
|
|
|
(13 |
) |
Interest
income (expense), net - related party
|
|
|
-
- |
|
|
|
28 |
|
|
|
(28 |
) |
|
|
-
- |
|
|
|
-
- |
|
Income
from equity investment in Equistar
Chemicals, LP
|
|
|
-
- |
|
|
|
-
- |
|
|
|
3 |
|
|
|
-
- |
|
|
|
3 |
|
Equity
in income of subsidiaries
|
|
|
266 |
|
|
|
873 |
|
|
|
-
- |
|
|
|
(1,139 |
) |
|
|
-
- |
|
Other
income (expense), net
|
|
|
-
- |
|
|
|
(17 |
) |
|
|
1 |
|
|
|
-
- |
|
|
|
(16 |
) |
Benefit
from (provision for) income taxes
|
|
|
-
- |
|
|
|
(305 |
) |
|
|
318 |
|
|
|
-
- |
|
|
|
13 |
|
Income
from discontinued operations, net of tax
|
|
|
-
- |
|
|
|
-
- |
|
|
|
283 |
|
|
|
-
- |
|
|
|
283 |
|
Net
income
|
|
$ |
266 |
|
|
$ |
569 |
|
|
$ |
570 |
|
|
$ |
(1,139 |
) |
|
$ |
266 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF INCOME
|
|
Successor
|
|
For
the Six Months Ended June 30, 2008
|
|
Millions of
dollars
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Sales
and other operating revenues
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
399 |
|
|
$ |
- - |
|
|
$ |
399 |
|
Cost
of sales
|
|
|
-
- |
|
|
|
-
- |
|
|
|
323 |
|
|
|
-
- |
|
|
|
323 |
|
Selling,
general and administrative expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
18 |
|
|
|
-
- |
|
|
|
18 |
|
Research
and development expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
1 |
|
Operating
income
|
|
|
-
- |
|
|
|
-
- |
|
|
|
57 |
|
|
|
-
- |
|
|
|
57 |
|
Interest
expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense on push-down debt
|
|
|
(15 |
) |
|
|
(15 |
) |
|
|
-
- |
|
|
|
15 |
|
|
|
(15 |
) |
Millennium
debt
|
|
|
-
- |
|
|
|
(12 |
) |
|
|
-
- |
|
|
|
-
- |
|
|
|
(12 |
) |
Interest
income (expense), net - related party
|
|
|
-
- |
|
|
|
54 |
|
|
|
(55 |
) |
|
|
-
- |
|
|
|
(1 |
) |
Interest
income |
|
|
-
- |
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
1 |
|
Loss
from equity investment in Equistar
Chemicals, LP
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(96 |
) |
|
|
-
- |
|
|
|
(96 |
) |
Effect
of push-down debt on loss from equity investment in
Equistar
|
|
|
-
- |
|
|
|
-
- |
|
|
|
96 |
|
|
|
-
- |
|
|
|
96 |
|
Equity
in income of subsidiaries
|
|
|
34 |
|
|
|
11 |
|
|
|
-
- |
|
|
|
(45 |
) |
|
|
-
- |
|
Other
income
|
|
|
-
- |
|
|
|
-
- |
|
|
|
2 |
|
|
|
-
- |
|
|
|
2 |
|
Benefit
from (provision) for income taxes
|
|
|
1 |
|
|
|
(6 |
) |
|
|
(7 |
) |
|
|
-
- |
|
|
|
(12 |
) |
Net
income (loss)
|
|
$ |
20 |
|
|
$ |
32 |
|
|
$ |
(2 |
) |
|
$ |
(30 |
) |
|
$ |
20 |
|
STATEMENT
OF INCOME
|
|
Predecessor
|
|
For
the Six Months Ended June 30, 2007
|
|
Millions of
dollars
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Sales
and other operating revenues
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
313 |
|
|
$ |
- - |
|
|
$ |
313 |
|
Cost
of sales
|
|
|
-
- |
|
|
|
-
- |
|
|
|
264 |
|
|
|
-
- |
|
|
|
264 |
|
Selling,
general and
administrative expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
34 |
|
|
|
-
- |
|
|
|
34 |
|
Research
and development expenses
|
|
|
-
- |
|
|
|
-
- |
|
|
|
2 |
|
|
|
-
- |
|
|
|
2 |
|
Operating
income
|
|
|
-
- |
|
|
|
-
- |
|
|
|
13 |
|
|
|
-
- |
|
|
|
13 |
|
Interest
expense, net
|
|
|
(4 |
) |
|
|
(23 |
) |
|
|
(4 |
) |
|
|
-
- |
|
|
|
(31 |
) |
Interest
income (expense), net – related party
|
|
|
-
- |
|
|
|
56 |
|
|
|
(56 |
) |
|
|
-
- |
|
|
|
-
- |
|
Other
income (expense), net
|
|
|
-
- |
|
|
|
(17 |
) |
|
|
1 |
|
|
|
-
- |
|
|
|
(16 |
) |
Income
from equity investment in Equistar
Chemicals LP
|
|
|
-
- |
|
|
|
-
- |
|
|
|
6 |
|
|
|
-
- |
|
|
|
6 |
|
Equity
in income of subsidiaries
|
|
|
285 |
|
|
|
822 |
|
|
|
-
- |
|
|
|
(1,107 |
) |
|
|
-
- |
|
Benefit
from (provision for) income taxes
|
|
|
-
- |
|
|
|
(293 |
) |
|
|
305 |
|
|
|
-
- |
|
|
|
12 |
|
Income
from discontinued operations,
net of tax
|
|
|
-
- |
|
|
|
-
- |
|
|
|
297 |
|
|
|
-
- |
|
|
|
297 |
|
Net
income
|
|
$ |
281 |
|
|
$ |
545 |
|
|
$ |
562 |
|
|
$ |
(1,107 |
) |
|
$ |
281 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF CASH FLOWS
|
|
Successor
|
|
For
the Six Months Ended June 30, 2008
|
|
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Millions of
dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
cash provided by (used
in) operating activities – continuing operations
|
|
$ |
89 |
|
|
$ |
(49 |
) |
|
$ |
(17 |
) |
|
$ |
- - |
|
|
$ |
23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayment
of notes receivable – related party
|
|
|
80 |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
80 |
|
Expenditures
for property,
plant and equipment
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(6 |
) |
|
|
-
- |
|
|
|
(6 |
) |
Proceeds
from sales of assets
|
|
|
-
- |
|
|
|
-
- |
|
|
|
16 |
|
|
|
-
- |
|
|
|
16 |
|
Net
cash provided by investing activities – continuing
operations
|
|
|
80 |
|
|
|
-
- |
|
|
|
10 |
|
|
|
-
- |
|
|
|
90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayment
of long-term debt
|
|
|
(158 |
) |
|
|
-
- |
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(158 |
) |
Proceeds
from notes payable – related party
|
|
|
(14 |
) |
|
|
25 |
|
|
|
14 |
|
|
|
-
- |
|
|
|
25 |
|
Other
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(2 |
) |
|
|
-
- |
|
|
|
(2 |
) |
Net
cash provided by (used
in) financing activities – continuing operations
|
|
|
(172 |
) |
|
|
25 |
|
|
|
12 |
|
|
|
-
- |
|
|
|
(135 |
) |
Increase
(decrease) in cash
and cash equivalents
|
|
|
(3 |
) |
|
|
(24 |
) |
|
|
5 |
|
|
|
-
- |
|
|
|
(22 |
) |
Cash
and cash equivalents
at beginning of period
|
|
|
3 |
|
|
|
24 |
|
|
|
24 |
|
|
|
-
- |
|
|
|
51 |
|
Cash
and cash equivalents at end of period
|
|
$ |
- - |
|
|
$ |
- - |
|
|
$ |
29 |
|
|
$ |
- - |
|
|
$ |
29 |
|
MILLENNIUM
CHEMICALS INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF CASH FLOWS
|
|
Predecessor
|
|
For
the Six Months Ended June 30, 2007
|
|
Millions of
dollars
|
|
Millennium
Chemicals
Inc.
|
|
|
Millennium
America
Inc.
|
|
|
Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Millennium
Chemicals
Inc.
and
Subsidiaries
|
|
Net
cash provided by (used
in) operating activities – continuing
operations
|
|
$ |
205 |
|
|
$ |
(289 |
) |
|
$ |
(15 |
) |
|
$ |
- - |
|
|
$ |
(99 |
) |
Net
used in operating activities – discontinued
operations
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(120 |
) |
|
|
-
- |
|
|
|
(120 |
) |
Net
cash provided by (used
in) operating activities
|
|
|
205 |
|
|
|
(289 |
) |
|
|
(135 |
) |
|
|
-
- |
|
|
|
(219 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advances
under loan agreements - related party
|
|
|
(200 |
) |
|
|
(300 |
) |
|
|
-
- |
|
|
|
-
- |
|
|
|
(500 |
) |
Expenditures
for property,
plant and equipment
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(6 |
) |
|
|
-
- |
|
|
|
(6 |
) |
Payments
to discontinued operations
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(104 |
) |
|
|
-
- |
|
|
|
(104 |
) |
Distributions
from affiliates in excess
of earnings
|
|
|
-
- |
|
|
|
-
- |
|
|
|
24 |
|
|
|
-
- |
|
|
|
24 |
|
Other
|
|
|
-
- |
|
|
|
-
- |
|
|
|
3 |
|
|
|
-
- |
|
|
|
3 |
|
Net
cash used in investing activities – continuing operations
|
|
|
(200 |
) |
|
|
(300 |
) |
|
|
(83 |
) |
|
|
-
- |
|
|
|
(583 |
) |
Net
proceeds from sale of discontinued
operations before
required
repayment of debt
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1,089 |
|
|
|
-
- |
|
|
|
1,089 |
|
Other
net cash provided by investing activities – discontinued
operations
|
|
|
-
- |
|
|
|
-
- |
|
|
|
89 |
|
|
|
-
- |
|
|
|
89 |
|
Net
cash provided by (used in) investing
activities
|
|
|
(200 |
) |
|
|
(300 |
) |
|
|
1,095 |
|
|
|
-
- |
|
|
|
595 |
|
Repayment
of long-term debt
|
|
|
-
- |
|
|
|
(390 |
) |
|
|
-
- |
|
|
|
-
- |
|
|
|
(390 |
) |
Intercompany
|
|
|
(5 |
) |
|
|
934 |
|
|
|
(929 |
) |
|
|
-
- |
|
|
|
-
- |
|
Other
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
cash provided by (used in) financing
activities –
continuing
operations
|
|
|
(5 |
) |
|
|
544 |
|
|
|
(928 |
) |
|
|
-
- |
|
|
|
(389 |
) |
Debt
required to be repaid upon sale
of discontinued operations
|
|
|
-
- |
|
|
|
-
- |
|
|
|
(99 |
) |
|
|
-
- |
|
|
|
(99 |
) |
Other
net cash provided by financing
activities –
discontinued
operations
|
|
|
-
- |
|
|
|
-
- |
|
|
|
23 |
|
|
|
-
- |
|
|
|
23 |
|
Net
cash provided by (used in) financing
activities
|
|
|
(5 |
) |
|
|
544 |
|
|
|
(1,004 |
) |
|
|
-
- |
|
|
|
(465 |
) |
Effect
of exchange
rate changes on cash
|
|
|
-
- |
|
|
|
-
- |
|
|
|
1 |
|
|
|
-
- |
|
|
|
1 |
|
Decrease
in cash and cash equivalents
|
|
|
-
- |
|
|
|
(45 |
) |
|
|
(43 |
) |
|
|
-
- |
|
|
|
(88 |
) |
Cash
and cash equivalents
at beginning of period
|
|
|
-
- |
|
|
|
62 |
|
|
|
59 |
|
|
|
-
- |
|
|
|
121 |
|
Cash
and cash equivalents at end of period
– continuing operations
|
|
$ |
- - |
|
|
$ |
17 |
|
|
$ |
16 |
|
|
$ |
- - |
|
|
$ |
33 |
|
Item
2. Management's
Discussion and Analysis of Financial Condition and Results of
Operations
This
discussion should be read in conjunction with information contained in the
Consolidated Financial Statements of Millennium Chemicals Inc., together with
its consolidated subsidiaries (collectively, “Millennium”), and the notes
thereto.
In
addition to comparisons of current operating results with the same period in the
prior year, Millennium has included, as additional disclosure, certain “trailing
quarter” comparisons of second quarter 2008 operating results to first quarter
2008 operating results. Millennium’s acetyls business and its joint
ventures’ businesses are highly cyclical, in addition to experiencing some less
significant seasonal effects. Trailing quarter comparisons may offer
important insight into current business directions.
The
consolidated statement of income for the three and six months ended June 30,
2008 reflects post-acquisition depreciation and amortization expense based on
the new value of the related assets and interest expense that resulted from the
debt used to finance the acquisition; therefore, the financial information for
the periods prior to and subsequent to the acquisition on December 20, 2007 is
not generally comparable. To indicate the application of a different
basis of accounting for the period subsequent to the acquisition, the 2007
financial information presents separately the period prior to the acquisition
(“Predecessor”) and the period after the acquisition (“Successor”).
References
to industry benchmark prices or costs, including the weighted average cost of
ethylene production, are generally to industry prices and costs reported by
Chemical Marketing Associates, Incorporated (“CMAI”), except that crude oil and
natural gas benchmark price references are to industry prices reported by
Platts, a reporting service of The McGraw-Hill Companies.
ACQUISITION
On
December 20, 2007, Basell AF S.C.A. (“Basell”) indirectly acquired the
outstanding common shares of Lyondell Chemical Company (together with its
consolidated subsidiaries, “Lyondell”). As a result, Lyondell became
an indirect wholly owned subsidiary of Basell, and Basell was renamed
LyondellBasell Industries AF S.C.A. (together with its consolidated
subsidiaries, “LyondellBasell Industries” and without Lyondell, the “Basell
Group”).
OVERVIEW
General—Millennium, a
manufacturer and marketer of chemicals, primarily acetyls and fragrance and
flavors chemicals, is a wholly owned subsidiary of Lyondell. As a
result of the acquisition of Lyondell by LyondellBasell Industries, Millennium
reassessed segment reporting based on the current management structure,
including the impact of the integration of Millennium’s businesses into the
LyondellBasell Industries portfolio of businesses. Based on this
analysis, Millennium concluded that it operates in, and management is focused
on, one reportable segment, the chemicals segment.
Millennium
has an ownership interest in Equistar Chemicals, LP (together with its
consolidated subsidiaries, “Equistar”), which is accounted for by Millennium
using the equity method. Other subsidiaries of Lyondell hold the
remaining interest in Equistar.
On May
15, 2007, Millennium completed the sale of its worldwide inorganic chemicals
business in a transaction valued at approximately $1.3 billion, including the
acquisition of working capital and the assumption of specified liabilities
directly related to the business (see Note 4 to the Consolidated Financial
Statements). Substantially all of the inorganic chemicals business
segment is being reported as a discontinued operation, including comparative
periods presented. Unless otherwise indicated, the following
discussion of Millennium’s operating results relates only to Millennium’s
continuing operations.
Acetyls
markets were stronger in the first six months of 2008 compared to the same
period in 2007. As a result, Millennium’s acetyls products benefited
from higher prices and margins, particularly for methanol, in the second quarter
and first six months of 2008 compared to the same periods in
2007. Fragrance and flavors products continued to show steady
performance in the 2008 and 2007 periods.
Equistar’s
operating results reflected lower product margins in the second quarter and
first six months of 2008 compared to the same periods in 2007 due primarily to
higher raw material costs. Equistar’s results of operations are
reviewed below on a 100% basis.
RESULTS
OF OPERATIONS
Revenues—Millennium’s revenues
of $193 million in the second quarter 2008 were 20% higher compared to
revenues of $161 million in the second quarter 2007, and revenues of
$399 million in the first six months of 2008 were 27% higher compared to
revenues of $313 million in the first six months of 2007 primarily due to the
effect of higher average sales prices for VAM and methanol, partially offset by
the effect of lower sales volumes.
Cost of Sales—Cost of sales of
$164 million was 15% higher in the second quarter 2008 compared to $142
million in the second quarter 2007, and cost of sales of $323 million was
22% higher in the first six months of 2008 compared to $264 million in the first
six months of 2007, primarily due to higher raw material costs.
SG&A Expenses—SG&A
expenses were $10 million in the second quarter 2008 compared to
$22 million in the second quarter 2007, while SG&A expenses were $18
million in the first six months of 2008 compared to $34 million in the
first six months of 2007. The decreases were primarily due to lower
provisions of $9 million for estimated environmental remediation costs in
each of the 2008 periods.
Operating
Income—Millennium had operating income of $19 million in the second
quarter 2008 compared to an operating loss of $4 million in the second quarter
2007. The improvement was primarily due to higher product margins
partially offset by lower sales volumes.
Operating
income was $57 million in the first six months of 2008 compared to
operating income of $13 million in the first six months of 2007, primarily
related to higher product margins.
Interest Expense—Interest
expense, including related party interest expense, interest expense on push-down
debt and interest on Millennium’s debt was $14 million in the second
quarter 2008 compared to $19 million in the second quarter 2007 and
$28 million in the first six months of 2008 compared to $38 million in the
first six months of 2007. The decreases reflect the repayment of
$220 million of principal amount of debt, which was partially offset by the
interest expense on promissory notes due 2012 issued in January 2008 to a
related party.
Other Income (Expense),
Net—Millennium had other expense, net of $1 million in the second
quarter 2008 compared to other expense, net, of $16 million in the second
quarter 2007 and other income of $2 million for the first six months of
2008 compared to other expense, net of $16 million for the six months of
2007. The 2007 periods included $14 million of debt repayment
premiums.
Income (loss) from Equity Investment
in Equistar—Millennium’s equity investment in Equistar, excluding the
effect of Millennium’s share of Equistar’s push-down debt, resulted in a loss of
$62 million in the second quarter 2008 compared to income of
$3 million in the second quarter 2007, and a loss of $96 million in
the first six months of 2008 compared to income of $6 million for the same
period of 2007. As a result of push-down debt, Millennium’s losses
from its equity investment in Equistar were reduced to
zero. Equistar’s operating results are reviewed further in the
discussion of Equity Investment in Equistar below.
Income
from Continuing Operations—Millennium’s income from continuing operations
was $3 million in the second quarter 2008 compared to income of $20 million
in the second quarter 2007 and income of $16 million in the first six
months of 2008 compared to a loss of $16 million in the first six months of
2007. The increases were primarily due to higher operating income
resulting from improved acetyls product margins.
Second
Quarter 2008 versus First Quarter 2008
Millennium’s
income from continuing operations was $3 million in the second quarter 2008
compared to income of $17 million in the first quarter 2008. The
decrease in profitability was primarily due to lower average sales prices
compared to a strong first quarter 2008, while raw material costs continued to
increase.
Segment
Analysis
At the
time of the acquisition of Lyondell by LyondellBasell Industries, Millennium
established a new chemicals business segment through which its operations are
managed as part of LyondellBasell Industries.
Millennium
operates in one reportable segment. Millennium’s chemicals business
segment produces and markets: acetyls, which include VAM, acetic acid
and methanol; and fragrance and flavors chemicals.
On May
15, 2007, Millennium completed the sale of its worldwide inorganic chemicals
business (see Note 4) and substantially all of the inorganic chemicals segment
was reclassified as a discontinued operation.
The
following table reflects summarized financial information for Millennium’s
chemicals segment. Other operating loss includes income and expense
not identified with the chemicals business, including certain of Millennium’s
environmental remediation costs and employee-related costs from predecessor
businesses.
|
|
Successor
|
|
|
Predecessor
|
|
|
Successor
|
|
|
Predecessor
|
|
|
|
For
the three months ended
|
|
|
For
six the months ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Millions of
dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
$ |
193 |
|
|
$ |
159 |
|
|
$ |
399 |
|
|
$ |
309 |
|
Other
|
|
|
- - |
|
|
|
2 |
|
|
|
- - |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
23 |
|
|
|
17 |
|
|
|
65 |
|
|
|
41 |
|
Other
|
|
|
(4 |
) |
|
|
(21 |
) |
|
|
(8 |
) |
|
|
(28 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from equity
investment in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equistar before effects of push-down
debt
|
|
|
(62 |
) |
|
|
3 |
|
|
|
(96 |
) |
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales volumes, in
millions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acetyls:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vinyl
Acetate Monomer (VAM) (pounds)
|
|
|
158 |
|
|
|
176 |
|
|
|
305 |
|
|
|
322 |
|
Acetic
acid (pounds)
|
|
|
160 |
|
|
|
168 |
|
|
|
314 |
|
|
|
327 |
|
Methanol
(gallons)
|
|
|
17 |
|
|
|
12 |
|
|
|
34 |
|
|
|
22 |
|
Chemicals
Segment
Revenues—Chemicals segment
revenues of $193 million in the second quarter 2008 were 21% higher
compared to revenues of $159 million in the second quarter 2007, while
revenues of $399 million in the first six months of 2008 were 29% higher
compared to revenues of $309 million in the first six months of 2007. The
increase in the second quarter and first six months of 2008 was primarily due to
the effects of higher average sales prices for VAM and methanol, partially
offset by the effect of lower sales volumes.
Operating Income—The chemicals
segment had operating income of $23 million in the second quarter 2008
compared to $17 million in the second quarter 2007 and operating income of
$65 million in the six months ended June 30, 2008 compared to
$41 million in the same period of 2007. The $6 million
improvement in the second quarter 2008 was primarily due to higher product
margins for methanol and VAM partially offset by the effect of lower sales
volumes for VAM. The $24 million improvement in the first six
months of 2008 was primarily due to higher product margins for methanol and
VAM.
Equity Investment in
Equistar
OVERVIEW
Equistar
manufactures and markets ethylene and its co-products, ethylene derivatives,
primarily polyethylene, and gasoline blending components, as well as
polypropylene.
As a
result of the acquisition of Lyondell by LyondellBasell Industries, Equistar
reassessed segment reporting based on the current management structure,
including the impact of the integration of Equistar’s businesses into the
LyondellBasell Industries portfolio of businesses. Based on this
analysis, Equistar concluded that management is focused on the chemicals segment
and the polymers segment. See “Segment Analysis” below for a
description of the segments.
In the
first six months of 2008 compared to the same period in 2007, record high prices
for crude oil and higher prices for natural gas liquids contributed to higher
raw material costs for chemical producers, putting pressure on chemical product
margins, particularly ethylene. Chemicals and polymers markets
generally experienced balanced supply and demand conditions with some weakening
of demand.
During
the second quarter and first six months of 2008 compared to the same periods in
2007, Equistar experienced lower profitability as sales price increases failed
to keep pace with significantly higher average raw material
costs. Equistar’s operating results in the second quarter and first
six months of 2008, compared to the same periods in 2007, reflected the effects
of lower product margins in both the chemicals and polymers
segments. The segment operating results are reviewed in the “Segment
Analysis” below.
Ethylene Raw Materials—Benchmark crude oil and
natural gas prices generally have been indicators of the level and direction of
movement of raw material and energy costs for ethylene and its co-products in
the chemicals segment. Ethylene and its co-products are produced from
two major raw material groups:
·
|
crude
oil-based liquids (“liquids” or “heavy liquids”), including naphthas,
condensates, and gas oils, the
prices of which are generally related to crude oil prices;
and
|
·
|
natural
gas liquids (“NGLs”), principally ethane and propane, the prices of which
are generally affected by natural gas
prices.
|
Although
the prices of these raw materials are generally related to crude oil and natural
gas prices, during specific periods the relationships among these materials and
benchmarks may vary significantly.
Equistar
has the ability to shift its ratio of raw materials used in the production of
ethylene and its co-products to take advantage of the relative costs of heavy
liquids and NGLs. However, this ability is limited and, in the first
six months of 2008, was not sufficient to offset the unprecedented differential
increase in the price of liquids versus NGLs and the failure of co-product price
increases to offset this differential increase.
The
following table shows the average U.S. benchmark prices for crude oil and
natural gas for the applicable three- and six-month periods, as well as
benchmark U.S. sales prices for ethylene, propylene, benzene and HDPE, which
Equistar produces and sells. The benchmark weighted average cost of
ethylene production, which is reduced by co-product revenues, is based on CMAI’s
estimated ratio of heavy liquid raw materials and NGLs used in U.S. ethylene
production and is subject to revision.
|
|
Average
Benchmark Price
|
|
|
|
For
the three months ended
|
|
|
For
the six months ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Crude
oil – dollars per barrel
|
|
|
123.90 |
|
|
|
64.87 |
|
|
|
110.95 |
|
|
|
61.43 |
|
Natural
gas – dollars per million BTUs
|
|
|
11.07 |
|
|
|
7.25 |
|
|
|
9.55 |
|
|
|
6.91 |
|
NWE
Naphtha-dollars per barrel
|
|
|
110.00 |
|
|
|
74.46 |
|
|
|
101.73 |
|
|
|
68.04 |
|
Weighted
average cost
of
ethylene production – cents per pound
|
|
|
55.46 |
|
|
|
33.79 |
|
|
|
52.62 |
|
|
|
31.34 |
|
Ethylene
– cents per pound
|
|
|
65.67 |
|
|
|
44.67 |
|
|
|
63.08 |
|
|
|
42.33 |
|
Propylene
– cents per pound
|
|
|
68.17 |
|
|
|
49.92 |
|
|
|
63.92 |
|
|
|
46.52 |
|
Benzene
– cents per gallon
|
|
|
397.67 |
|
|
|
394.67 |
|
|
|
381.50 |
|
|
|
373.83 |
|
HDPE
– cents per pound
|
|
|
91.67 |
|
|
|
69.67 |
|
|
|
88.33 |
|
|
|
66.83 |
|
While the
increases in natural gas prices were not as dramatic as those of crude oil, NGL
prices were significantly higher during the second quarter and first six months
of 2008 compared to the same periods in 2007. These increases were
indicative of the pressure on Equistar’s raw material costs, primarily crude
oil-based, but also NGL-based.
Revenues—Equistar’s
revenues of $4,136 million in the second quarter 2008 were 17% higher
compared to revenues of $3,534 million in the second quarter 2007, while
the first six months of 2008 revenues of $7,957 million were 24% higher compared
to revenues of $6,403 million in the first six months of 2007. The
higher revenues in the second quarter and first six months of 2008 reflected the
effects of higher average sales prices, partially offset by the effect of lower
sales volumes, compared to the same periods in 2007. As noted in the
table above, benchmark sales prices in the second quarter 2008 averaged higher
compared to the second quarter 2007. Ethylene and derivative sales
volumes in the second quarter 2008 were 8% lower, while ethylene co-product
sales volumes were 18% lower and polymer sales volumes were 5% lower compared to
the second quarter 2007.
Operating
Income—Equistar had an operating loss of $293 million in the second
quarter 2008 compared to operating income of $91 million in the second
quarter 2007 and an operating loss of $457 million in the first six months
of 2008 compared to operating income of $154 million in the first six
months of 2007. The operating losses in the second quarter and first
six months of 2008 were primarily due to lower product margins as sales prices
did not increase as rapidly as raw material costs compared to the same periods
in 2007. In addition, depreciation and amortization expense increased
by $63 million and $121 million in the second quarter and first six months of
2008, respectively, as a result of the higher values assigned to Equistar’s
assets in the acquisition.
Other
Other
operations include Millennium’s unallocated operating expenses that are not
identified with the reportable business segment, including certain of
Millennium’s environmental remediation costs and employee-related costs from
predecessor businesses.
Other
operating losses were $4 million and $21 million in the second quarter
2008 and 2007, respectively, and $8 million and $28 million in the
first six months of 2008 and 2007, respectively. The decreases in the
second quarter and first six months of 2008 reflected lower environmental costs
in the second quarter 2008 and first six months of 2008.
FINANCIAL
CONDITION
Operating Activities—Operating
activities of continuing operations provided cash of $23 million in the
first six months of 2008 and used cash of $99 million in the first six
months of 2007. The $122 million change primarily reflected the
higher operating results in the first six months of 2008, while the first six
months of 2007 included higher U.S. federal income tax payments.
Operating
activities of discontinued operations used cash of $120 million in the first six
months of 2007 primarily due to increases in working capital and lower operating
results in the 2007 period.
Investing Activities—Investing
activities of continuing operations provided cash of $90 million in the
first six months of 2008 and used cash of $583 million in the first six
months of 2007. The cash provided in the first six months of 2008
primarily reflected an $80 million payment received from Equistar under
revolving loan agreements executed in June 2007. The first six months
of 2007 included advances of $500 million to Equistar under revolving loan
agreements executed in June 2007 and net payments to discontinued operations of
$104 million.
Investing
activities for the first six months of 2007 also included the
$1,089 million of cash proceeds from the sale of the worldwide inorganic
chemicals business, which were used to reduce debt and for the above-noted
advances to Equistar.
Investing
activities of discontinued operations provided cash of $89 million in the first
six months of 2007. Payments from Millennium’s continuing operations
of $104 million were partially offset by capital expenditures of
$15 million.
Financing Activities—Financing
activities of Millennium’s continuing operations used cash of $135 million
in the first six months of 2008 and $389 million in the first six months of 2007
primarily for debt repayment. During the first six months of 2008,
Millennium repaid the remaining $158 million of its 4% Convertible Senior
Debenture. Also, during the first six months of 2008, Millennium
issued promissory notes to a subsidiary of Lyondell under loan agreements with
total availability of $2,000 million, and borrowed $25 million under these
agreements. The notes mature on December 20, 2012, or earlier upon demand, and
bear interest, which is payable quarterly, at the London Interbank Offered Rate
(“LIBOR”) plus 4%.
In the
first six months of 2007, Millennium repaid the remaining $373 million
principal amount of its 9.25% Senior Notes due 2008, paying a premium of
$13 million, and $4 million principal amount of its 7.625% Senior
Debentures due 2026. The repayment of debt upon the May 15, 2007
sale of the discontinued operations used cash of $99 million.
Financing
activities of discontinued operations provided cash of $23 million in the first
six months of 2007.
Liquidity and Capital
Resources—At June 30, 2008, Millennium had $29 million of cash on
hand. Millennium has outstanding letters of credit of $7 million
and related cash collateral of $2 million, which is included in “Other
assets, net,” at June 30, 2008. As of June 30, 2008, total debt,
including current maturities, under which Millennium is the primary obligor, was
$171 million.
In view
of the interrelated nature of the credit and liquidity position of
LyondellBasell Industries and its subsidiaries, and pursuant to Staff Accounting
Bulletin Topic 5(j) of the Securities and Exchange Commission, Millennium has
recognized debt for which it is not the primary obligor, but which it has
guaranteed (the push-down debt), that was used in the acquisition of Lyondell by
LyondellBasell Industries.
As a
result of the December 20, 2007 acquisition of Lyondell by LyondellBasell
Industries, Millennium recognized in its financial statements, as of June 30,
2008, $316 million of acquisition-related or push-down debt for which it is
a guarantor, as described below, but is not the primary obligor, and reduced its
investment in Equistar by $1,556 million to zero to reflect the push down
to Equistar of debt of LyondellBasell Industries guaranteed by Equistar (see
Notes 1, 6 and 11 to the Consolidated Financial
Statements). Millennium does not expect that it will be required to
fund the push-down debt in the foreseeable future.
Millennium
is a limited guarantor of certain debt of the Basell Group and
Lyondell. Millennium may not incur additional indebtedness in excess
of 15% of Millennium’s Consolidated Net Tangible Assets (“CNTA”), as defined in
the indenture for Millennium’s 7.625% Senior Debentures due 2026. At
June 30, 2008, Millennium’s CNTA was $2,105 million.
The
guaranteed Basell Group debt, at June 30, 2008, includes an $8,000 million
Senior Secured Interim Loan and 8.375% High Yield Notes due 2015, comprising
borrowings of $615 million and €500 million
($789 million). The Senior Secured Interim Loan, together with
proceeds of other borrowings discussed below, was used to finance the
acquisition of Lyondell. If not repaid or exchanged, prior to the 12
months tenure, the Senior Secured Interim Loan converts to a senior secured loan
in December 2008 and is due June 2015. The Senior Secured Interim
Loan bears interest at LIBOR plus an initial margin of 4.625%, which margin
increased in June 2008 to 5.125%, and increases by 0.5% for each three-month
period thereafter, subject to a maximum interest rate of 12% per annum (or 12.5%
in the event of certain rating declines). Through a series of
actions, the validity of which LyondellBasell Industries disputes, the joint
lead arrangers (“JLAs”) have attempted to increase the applicable rate under the
Senior Secured Interim Loan to 12% per annum. Since June 20, 2008,
LyondellBasell Industries has been paying 12% interest, which is approximately
4% higher than the currently applicable rate under the Senior Secured Interim
Loan as at June 30, 2008, in order to avoid any allegation of default by
the lenders. LyondellBasell Industries has protested the higher rate
of interest and has reserved its right to recover any such amounts based upon a
determination that the JLAs’ attempt to impose a rate increase is not supported
by the terms of the applicable loan documentation.
In
addition, Millennium is a limited guarantor under a Senior Secured Credit
Facility and a Senior Secured Inventory-Based Credit Facility entered into on
December 20, 2007, in connection with the acquisition of Lyondell by
LyondellBasell Industries. Lyondell and other subsidiaries of the
Basell Group are borrowers under the Senior Secured Credit Facility, which
includes a six-year $2,000 million term loan A facility due 2013; a
seven-year $7,550 million and €1,300 million term loan B facility due
2014; and a six-year $1,000 million multicurrency revolving credit facility
due 2013. Lyondell, Equistar and a subsidiary of the Basell Group are
borrowers under the Senior Secured Inventory-Based Credit Facility.
At June
30, 2008, amounts borrowed by the Basell Group under the Senior Secured Credit
Facility consisted of $488 million borrowed under term loan A, €1,294
million ($2,043 million) under term loan B, and Lyondell borrowings
included $1,465 million borrowed under term loan A and $7,512 million
under term loan B. At June 30, 2008, borrowings of
$1,183 million were outstanding under the Senior Secured Inventory-Based
Credit Facility, $1,053 million on the part of Lyondell and
$130 million on the part of the Basell Group. There was no
outstanding borrowing under the senior secured revolving credit facility as of
June 30, 2008.
Historically,
Millennium has financed its operations primarily through cash generated from its
operations, cash distributions from Equistar, and debt
financing. Cash generated from operations is, to a large extent,
dependent on economic, financial, competitive and other factors affecting
Millennium’s businesses and the timing and amount of cash distributions from
Equistar. With the sale of the inorganic chemicals business,
Millennium could become more reliant on cash distributions from
Equistar. The amount of cash distributions received from Equistar is
affected by Equistar’s results of operations and current and expected future
cash flow requirements. Millennium received cash distributions of
$30 million from Equistar in the first six months of 2007 and none in the
first six months of 2008.
Subsequent
to the acquisition of Lyondell, LyondellBasell Industries manages the cash and
liquidity of Millennium and its other subsidiaries as a single group and a
global cash pool. Substantially all of the group’s cash is managed
centrally, with operating subsidiaries participating through an intercompany
uncommitted revolving credit facility.
Millennium
has up to $1,975 million available under a loan agreement with a Lyondell
subsidiary subject to availability through LyondellBasell Industries’ global
cash management program.
Millennium
believes that conditions will be such that its cash balances, cash generated
from operating activities and cash distributions from Equistar, funds from lines
of credit and cash generated from funding under various liquidity facilities
available to Millennium through Lyondell and LyondellBasell Industries, will be
adequate to meet anticipated future cash requirements, including scheduled debt
repayments, necessary capital expenditures and ongoing operations.
The
majority of the operating subsidiaries of LyondellBasell Industries, including
Millennium and Equistar, have provided guarantees or collateral for the new debt
of various LyondellBasell Industries subsidiaries totaling approximately
$22 billion that was used primarily to acquire
Lyondell. Accordingly, the major bond rating agencies have assigned a
corporate rating to LyondellBasell Industries as a group relevant to such
borrowings. Management believes this corporate rating is reflective of the
inherent credit for Millennium, as well as for the group as a
whole.
In May
2008, Moody’s Investors Service affirmed LyondellBasell Industries’ corporate
rating at B1 and lowered its outlook for LyondellBasell Industries from stable
to negative citing LyondellBasell Industries’ lower than expected operating
results and the effect the current weakness in the U.S. olefins market may have
on LyondellBasell Industries’ plan to substantially reduce debt. In
April 2008, Standard & Poor’s Rating Services (“S&P”) affirmed
LyondellBasell Industries’ corporate rating at B+ and lowered its outlook for
LyondellBasell Industries from stable to negative. The outlook
revision cited increased risks to LyondellBasell Industries in 2008 including
weaker economic growth in the U.S. and Europe and a significant increase in oil
prices.
In March
2008, LyondellBasell Industries entered into a senior unsecured
$750 million, eighteen-month revolving credit facility, under which
Lyondell and a subsidiary of the Basell Group are borrowers. The
$750 million revolving credit facility is in addition to the existing
credit facilities available to LyondellBasell Industries and is provided to
LyondellBasell Industries by Access Industries Holdings, LLC, an affiliate of
Access Industries, which indirectly owns LyondellBasell
Industries. The revolving credit facility has substantially the same
terms as the Senior Secured Credit Facility except that it is unsecured and is
not guaranteed by the subsidiaries of LyondellBasell Industries.
As of
June 30, 2008, there were no borrowings outstanding under the
facility. At each borrower’s option, loans under the revolving credit
facility bear interest until the first full fiscal quarter commencing on or
after June 30, 2008, at rates equal to LIBOR plus 6% or the higher of the (i)
federal funds rate plus 0.5% and (ii) prime rate, plus, in each case,
5%. Thereafter, interest rates will be adjusted, from time to time,
based upon the First Lien Senior Secured Leverage Ratio as calculated at such
time. Neither Millennium nor Equistar can borrow under this
facility.
Millennium’s
indenture contains certain covenants; however Millennium is no longer prohibited
from making certain restricted payments, including dividends to Lyondell, nor is
it required to maintain financial ratios as a result of the repayment in June
2007 of its 9.25% Senior Notes due 2008. The remaining covenants are
described in Note 13 to Millennium’s Consolidated Financial Statements
included in Millennium’s Annual Report on Form 10-K for the year ended December
31, 2007. There have been no changes in the terms of the covenants or
the guarantees in the quarter ended June 30, 2008.
Debt Agreement
Amendments―Under the terms of
the financing for the Lyondell acquisition, the JLAs retained the right to flex
certain provisions of the financing, including pricing and the reallocation and
retranching of the Term Loans. Effective April 30, 2008, the JLAs
exercised the price flex provisions and, in conjunction with the exercise, the
Senior Secured Credit Facility was amended to (i) convert each of the U.S.
Tranche B Dollar Term Loan and the German Tranche B Euro Term Loan into three
separate tranches, some of which tranches are subject to a prepayment penalty,
(ii) increase interest rates and fee rates by 0.5%, (iii) establish a LIBOR
floor of 3.25% on the U.S. Tranche B Dollar Term Loan, (iv) modify certain debt
covenants, including increasing a general debt basket from
$750 million to $1,000 million, eliminating an interest rate hedging
requirement, increasing the asset backed facility basket by $500 million,
and adding a covenant prohibiting reduction of aggregate commitments under the
Revolving Credit Facility with Access Industries before its initial maturity,
(v) amend the calculation of Consolidated EBITDA, as defined, for the purpose of
determining compliance with the debt requirements, to reflect adjustments to
present 2007 cost of sales in accordance with FIFO inventory accounting, and
(vi) make other changes, including technical and typographical
corrections.
In
conjunction with the exercise by the JLAs of their flex rights, additional
amendments were made to each of the Senior Secured Interim Loan, Senior Secured
Inventory-Based Credit Facility, Revolving Credit Facility with Access
Industries and Accounts Receivable Securitization Facility. The
amendments to the Senior Secured Interim Loan and Senior Secured Inventory-Based
Credit Facility and the Revolving Credit Facility with Access Industries were
effective on April 30, 2008. The amendments to the Accounts
Receivable Securitization Facility were effective on May 6, 2008.
Each of
the Senior Secured Interim Loan, the Senior Secured Inventory-Based Credit
Facility, the Accounts Receivable Securitization Facility and Revolving Credit
Facility with Access Industries were amended to (i) conform to certain of the
amendments to the Senior Secured Credit Facility and (ii) make other changes,
including technical and typographical corrections. In addition, the
Senior Secured Inventory-Based Credit Facility was amended to allow Lyondell the
future option to increase the aggregate amount of commitments under the facility
by a further $500 million.
Under the
terms of the Senior Secured Inventory-Based Credit Facility, as amended,
Lyondell could elect to increase commitments under the facility by up to an
aggregate $1,100 million. Effective April 30, 2008, Lyondell
exercised the option to increase the facility by $600 million and, as a result,
aggregate commitments under the facility increased from $1,000 million to $1,600
million. Concurrent with the exercise of the increase in commitments,
Lyondell Chemical Company became a lien grantor and added the following as
collateral: (i) a first priority pledge of all equity interests owned by
Lyondell Chemical Company in, and all indebtedness owed to it by, LyondellBasell
Receivables I, LLC (the seller under the Accounts Receivable Securitization
Facility) and (ii) a first priority security interest in all accounts
receivable, inventory and related assets owned by Lyondell Chemical Company,
subject to customary exceptions.
Effects of a breach—A breach
by Millennium or any other obligor of the covenants or the failure to pay
principal and interest when due under any of the Senior Secured Credit Facility,
Senior Secured Interim Loan, Senior Secured Inventory-Based Credit Facility,
Accounts Receivable Securitization Facility or other indebtedness of Millennium
or its affiliates could result in a default or cross-default under all or some
of those instruments. If any such default or cross-default occurs,
the applicable lenders may elect to declare all outstanding borrowings, together
with accrued interest and other amounts payable thereunder, to be immediately
due and payable. In such circumstances, the lenders under the Senior
Secured Credit Facility and the Senior Secured Inventory-Based Credit Facility
also have the right to terminate any commitments they have to provide further
borrowings, and the counterparties under the Accounts Receivable Securitization
Facility may terminate further purchases of interests in accounts receivable and
receive all collections from previously sold interests until they have collected
on their interests in those receivables, thus reducing the entity’s
liquidity. In addition, following such an event of default, the
lenders under the Senior Secured Credit Facility and the Senior Secured Interim
Loan and the counterparties under the Senior Secured Inventory-Based Credit
Facility have the right to proceed against the collateral granted to them to
secure the obligations, which in some cases includes Millennium’s available
cash. If the obligations under the Senior Secured Credit Facility,
the Senior Secured Interim Loan, the Senior Secured Inventory-Based Facility,
Accounts Receivable Securitization Facility or any other material financing
arrangement were to be accelerated, it is not likely that the obligors would
have, or be able to obtain, sufficient funds to make these accelerated payments,
and as a result Millennium or one or more of its subsidiaries could be forced
into bankruptcy or liquidation.
Off-Balance Sheet
Arrangements—Millennium is not a party to any contractual arrangements
that fall within the Securities and Exchange Commission’s definition of
off-balance sheet arrangements.
Equistar Liquidity and Capital
Resources—At June 30, 2008, Equistar’s long-term debt, under which
Equistar is the primary obligor, was $130 million, and there were no
current maturities. In addition, Equistar recognized in its financial
statements a total of $17,648 million of acquisition-related or push-down
debt for which it is a guarantor, as described below, but is not the primary
obligor (see Note 11 to the Consolidated Financial Statements). As a
result of recognizing the push-down debt in its financial statements, Equistar
has a $10,106 million deficit in partners’ capital; however, Equistar does
not expect that it will be required to fund a substantial portion of the
push-down debt.
LyondellBasell
Industries manages the cash and liquidity of Equistar and its other subsidiaries
as a single group and a global cash pool. Substantially all of the
group’s cash is managed centrally, with operating subsidiaries participating
through an intercompany uncommitted revolving credit facility. The majority of
the operating subsidiaries of LyondellBasell Industries, including Millennium
Chemicals, certain of its subsidiaries and Equistar, have provided guarantees or
collateral for the new debt of various LyondellBasell Industries subsidiaries
totaling approximately $22 billion that was used primarily to acquire
Lyondell. Accordingly, the major bond rating agencies have assigned a
corporate rating to LyondellBasell Industries as a group relevant to such
borrowings. Management believes this corporate rating is reflective of the
inherent credit for Equistar, as well as for the group as a whole.
At June
30, 2008, Equistar had cash on hand of $23 million. The total amount
available to borrowers under both the $1,600 million Senior Secured
Inventory-Based Credit Facility and the $1,150 million Accounts Receivable
Securitization Facility totaled approximately $241 million, giving effect
to a total minimum unused availability requirement of $100 million under
the Accounts Receivable Securitization Facility and the Senior Secured
Inventory-Based Credit Facility and the total amount of outstanding letters of
guarantee and letters of credit under the Senior Secured Inventory-Based Credit
Facility. In addition, Equistar has up to $1,800 million
available under the loan agreement with a Lyondell subsidiary subject to
availability through LyondellBasell Industries’ global cash management
program.
Equistar
believes that its cash balances, cash generated from operating activities, funds
from lines of credit and cash generated from funding under various liquidity
facilities available to Equistar through LyondellBasell Industries will be
adequate to meet anticipated future cash requirements, including scheduled debt
repayments, necessary capital expenditures, and ongoing operations.
CURRENT
BUSINESS OUTLOOK
Through
mid-August 2008, conditions within acetyls have been relatively consistent with
the second quarter 2008, although raw material cost pressures and volatility
create an uncertain outlook for acetyls products and for Millennium’s equity
investment in Equistar. The fragrance and flavors products should
continue their steady performance.
CRITICAL
ACCOUNTING POLICIES
Millennium
applies those accounting policies that management believes best reflect the
underlying business and economic events, consistent with accounting principles
generally accepted in the U.S. Inherent in such policies are
certain key assumptions and estimates made by management. Management
periodically updates its estimates used in the preparation of the financial
statements based on its latest assessment of the current and projected business
and general economic environment. Information regarding Millennium’s
Critical Accounting Policies is included in Item 7 of Millennium’s Annual
Report on Form 10-K for the year ended December 31, 2007.
ACCOUNTING
AND REPORTING CHANGES
For a
discussion of the potential impact of new accounting pronouncements on
Millennium’s consolidated financial statements, see Note 2 to the Consolidated
Financial Statements.
Item
3. Disclosure of Market
Risk
Millennium’s
exposure to market risk is described in Item 7A of its Annual Report on Form
10-K for the year ended December 31, 2007. Millennium’s exposure
to market risk has not changed materially in the quarter ended June 30,
2008.
Item
4. Controls and
Procedures
Millennium
performed an evaluation, under the supervision and with the participation of its
management, including the President and Chief Executive Officer (principal
executive officer) and the Chief Financial Officer (principal financial
officer), of the effectiveness of Millennium’s disclosure controls and
procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as of June 30, 2008. Based upon that
evaluation, the President and Chief Executive Officer and the Chief Financial
Officer concluded that Millennium’s disclosure controls and procedures are
effective.
There
were no changes in Millennium’s internal control over financial reporting that
occurred during Millennium’s last fiscal quarter (the second quarter 2008) that
have materially affected, or are reasonably likely to materially affect,
Millennium’s internal control over financial reporting.
FORWARD-LOOKING
STATEMENTS
Certain
of the statements contained in this report are “forward-looking statements”
within the meaning of the federal securities laws. Forward-looking
statements can be identified by words such as “estimate,” “believe,” “expect,”
“anticipate,” “plan,” “budget” or other words that convey the uncertainty of
future events or outcomes. Many of these forward-looking statements
have been based on expectations and assumptions about future events that may
prove to be inaccurate. While management considers these expectations
and assumptions to be reasonable, they are inherently subject to significant
business, economic, competitive, regulatory and other risks, contingencies and
uncertainties, most of which are difficult to predict and many of which are
beyond Millennium’s control. Millennium’s actual results (including
the results of its joint ventures) could differ materially from those
anticipated in these forward-looking statements as a result of certain factors,
including but not limited to the following:
·
|
the
availability, cost and price volatility of raw materials and
utilities,
|
·
|
the
supply/demand balances for Millennium’s and its joint ventures’ products,
and the related effects of industry production capacities and operating
rates,
|
·
|
uncertainties
associated with the U. S. and worldwide
economies,
|
·
|
legal,
tax and environmental proceedings,
|
·
|
the
cyclical nature of the chemical
industry,
|
·
|
Millennium’s
ability to service its
indebtedness,
|
·
|
available
cash and access to capital markets,
|
·
|
technological
developments,
|
·
|
operating
interruptions (including leaks, explosions, fires, weather-related
incidents, mechanical failure, unscheduled downtime, supplier disruptions,
labor shortages or other labor difficulties, transportation interruptions,
spills and releases and other environmental
risks),
|
·
|
current
and potential governmental regulatory actions in the U. S. and in other
countries,
|
·
|
international
political unrest and terrorist
acts,
|
·
|
competitive
products and pricing pressures,
|
·
|
Millennium’s
ability to implement its business strategies, including integration with
LyondellBasell Industries, and
|
·
|
risks
of doing business outside the U.S., including foreign currency
fluctuations.
|
Any of
these factors, or a combination of these factors, could materially affect
Millennium’s or its joint ventures’ future results of operations and the
ultimate accuracy of the forward-looking statements. These
forward-looking statements are not guarantees of Millennium’s or its joint
ventures’ future performance, and Millennium’s or its joint ventures’ actual
results and future developments may differ materially from those projected in
the forward-looking statements. Management cautions against putting
undue reliance on forward-looking statements or projecting any future results
based on such statements or present or prior earnings levels.
All
forward-looking statements in this Form 10-Q are qualified in their entirety by
the cautionary statements contained in this section, elsewhere in this report
and in Millennium’s Annual Report on Form 10-K for the year ended December 31,
2007. See “Item 1. Legal Proceedings,” “Item
1A. Risk Factors” and “Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of Operations.” These
factors are not necessarily all of the important factors that could affect
Millennium and its joint ventures. Use caution and common sense when
considering these forward-looking statements. Millennium does not
intend to update these statements unless securities laws require it to do
so.
In
addition, this Form 10-Q contains summaries of contracts and other
documents. These summaries may not contain all of the information
that is important to an investor, and reference is made to the actual contract
or document for a more complete understanding of the contract or document
involved.
PART
II. OTHER INFORMATION
Item
1. Legal
Proceedings
There
have been no material developments with respect to Millennium’s legal
proceedings previously disclosed in the Annual Report on Form 10-K for the year
ended December 31, 2007 and the Quarterly Report on Form 10-Q for the
quarter ended March 31, 2008, except as disclosed below:
Litigation Matters—Together
with alleged past manufacturers of lead-based paint and lead pigments for use in
paint, Millennium has been named as a defendant in various legal proceedings
alleging personal injury, property damage, and remediation costs allegedly
associated with the use of these products. Since the beginning of
2007, 38 cases have been dismissed either voluntarily, upon defendants’ motion,
or tried to a jury verdict favorable to defendants, including
Millennium. Millennium currently remains named a defendant in
17 cases arising from Glidden’s manufacture of lead
pigments. These cases are in various stages of the litigation
process. Of the 17 cases, most seek damages for personal injury and
are brought by individuals, and four of the cases seek damages and abatement
remedies based on public nuisance and are brought by states, cities and/or
counties in three states (California, Ohio and Rhode Island).
On
October 29, 2002, after a trial in which the jury deadlocked, the court in State
of Rhode Island v. Lead Industries Association, Inc., et al. (which commenced in
the Superior Court of Providence, Rhode Island, on October 13, 1999) declared a
mistrial. The sole issue before the jury was whether lead pigment in
paint in and on public and private Rhode Island buildings constituted a “public
nuisance.” The new trial in this case began on November 1,
2005. On February 22, 2006, a jury returned a verdict in favor of the
State of Rhode Island finding that the cumulative presence of lead pigments in
paints and coatings on buildings in the state constitutes a public nuisance;
that a Millennium subsidiary and other defendants either caused or substantially
contributed to the creation of the public nuisance; and that those defendants,
including the Millennium subsidiary, should be ordered to abate the public
nuisance. On February 28, 2006, the judge held that the state could
not proceed with its claim for punitive damages. On February 26, 2007, the court
issued its decision denying the post-verdict motions of the defendants,
including Millennium, for a mistrial or a new trial. The court
concluded that it would enter an order of abatement and appoint a special master
to assist the court in determining the scope of the abatement
remedy. On March 16, 2007, the court entered a final judgment on the
jury’s verdict. On March 20, 2007, Millennium filed its notice of
appeal with the Rhode Island Supreme Court. On December 18, 2007, the
trial court appointed two special masters to serve as “examiners” and to assist
the trial court in the proposed abatement proceedings. On May 15,
2008, the Rhode Island Supreme Court heard oral argument on, among other things,
Millennium’s appeal of the jury’s verdict in favor of the State of Rhode
Island. On July 1, 2008, the Rhode Island Supreme Court unanimously
reversed the jury’s verdict and subsequent judgment against Millennium and the
other defendants, holding that the trial court should have granted Millennium’s
motion to dismiss for failure to state a claim. The Rhode Island
Supreme Court’s verdict effectively ends this legal proceeding.
Environmental Matters—In
December 2006, the State of Texas filed a lawsuit in the District Court, Travis
County, Texas, against Equistar and its owners, Lyondell and Millennium,
alleging past violations of various environmental regulatory requirements at
Equistar’s Channelview, Chocolate Bayou and La Porte, Texas facilities and
Millennium’s La Porte, Texas facility, and seeking an unspecified amount of
damages. The previously disclosed Texas Commission on Environmental
Quality (“TCEQ”) notifications alleging noncompliance of emissions monitoring
requirements at Equistar’s Channelview facility and Millennium’s La Porte
facility and seeking civil penalties of $167,000 and $179,520, respectively,
have been included as part of this lawsuit. In July 2008, Millennium
signed an Agreed Final Judgment resolving this lawsuit. Under the
terms of the settlement, Equistar Chemicals and Millennium Petrochemicals Inc.
each agreed to pay $3,250,000 in penalties (with $500,000 being offset by
funding of various local supplemental environmental projects by each
company). The companies also agreed to each pay $250,000 in attorney
fees to the state. This agreement resolved outstanding alleged
violations at several company-owned and/or operated Texas
facilities. No other additional expenditures are
required. The settlement is still subject to public comment and final
review by the Texas Attorney General and the district court.
A
Millennium subsidiary has been identified as a potentially responsible party
(“PRP”) with respect to the Kalamazoo River Superfund Site. The site
involves cleanup of river sediments and floodplain soils contaminated with
polychlorinated biphenyls, cleanup of former paper mill operations, and cleanup
and closure of landfills associated with the former paper mill
operations. Litigation concerning the matter commenced by the State
of Michigan in December 1987 was recently dismissed, although the State reserved
its right to bring certain claims in the future if the issues are not resolved
in the CERCLA process. Millennium’s ultimate liability for the
Kalamazoo River Superfund Site will depend on many factors that have not yet
been determined, including the ultimate remedy selected, the determination of
natural resource damages, the number and financial viability of the other PRPs,
and the determination of the final allocation among the PRPs.
Item
1A. Risk Factors
There
have been no material developments with respect to Millennium’s risk factors
previously disclosed in the Annual Report on Form 10-K for the year ended
December 31, 2007 and the Quarterly Report on Form 10-Q for the quarter ended
March 31, 2008, except as disclosed below:
Risks
Relating to the Businesses
Costs
of raw materials and energy, as well as reliability of supply, may result in
increased operating expenses and reduced results of operations.
Millennium
and its joint ventures purchase large amounts of raw materials and energy for
their businesses. The cost of these raw materials and energy, in the
aggregate, represents a substantial portion of their operating
expenses. The costs of raw materials and energy used for acetyls and
Equistar’s products generally follow price trends of, and vary with the
market conditions for, crude oil and natural gas, which may be highly volatile
and cyclical. Many raw material and energy costs are at or near
historically record high levels, and a weak U.S. dollar adds to the volatility
in Millennium and its joint ventures’ raw material costs. There have
been, and will likely continue to be, periods of time when Millennium and its
joint ventures are unable to pass raw material and energy cost increases on to
customers quickly enough to avoid adverse impacts on their results of
operations. Customer consolidation also has made it more difficult to
pass along cost increases to customers. The results of operations of
Millennium and its joint ventures have been, and could be in the future,
significantly affected by increases and volatility in these
costs. Cost increases also may increase working capital needs, which
could reduce liquidity and cash flow for Millennium and its joint
ventures. In addition, when raw material and energy costs increase
rapidly and are passed along to customers as product price increases, the credit
risks associated with certain customers can be compounded. To the
extent Millennium and its joint ventures increase their product sales prices to
reflect rising raw material and energy costs, demand for products may decrease
as customers reduce their consumption or use substitute products, which may have
an adverse impact on Millennium’s or its joint ventures’ results of
operations.
In
addition, higher North American natural gas prices relative to natural gas
cost-advantaged regions, such as the Middle East, have diminished the ability of
many chemical producers to compete internationally since natural gas prices
affect a significant portion of the industry’s raw materials and energy sources.
This environment has in the past caused and may in the future cause a
reduction in Millennium’s or Equistar’s exports, and has in the past reduced and
may in the future reduce the competitiveness of U.S. and European producers.
It also has in the past increased the competition for product sales within
North America and Europe, as production that would otherwise have been sold in
other geographic regions was instead offered for sale in these regions,
resulting in excess supply and lower margins in North America and Europe, and
may do so in the future.
Furthermore,
for Millennium and its joint ventures, there are a limited number of suppliers
for some of their raw materials and utilities and, in some cases, the number of
sources for and availability of raw materials is specific to the particular
geographic region in which a facility is located. In addition, for
some products of Millennium and its joint ventures, the facilities and/or
distribution channels of raw material suppliers and Millennium and its joint
ventures form an integrated system. This is especially true in the
U.S. Gulf Coast where the infrastructure of the chemical and refining industries
is tightly integrated such that a major disruption of supply of a given
commodity can negatively affect numerous participants, including suppliers of
other raw materials. If one or more of Millennium’s or its joint
ventures’ significant suppliers were unable to meet its obligations under
present supply arrangements, raw materials become unavailable within the
geographic area from which they are otherwise sourced, or supplies are otherwise
disrupted, Millennium’s or its joint ventures’ businesses could suffer reduced
supplies or be forced to incur increased costs for their raw materials, which
would have a direct negative impact on plant operations. For example,
Hurricanes Katrina and Rita negatively affected crude oil and natural gas
supplies, as well as supplies of some of Millennium’s and its joint ventures’
other raw materials, contributing to increases in raw material prices during the
second half of 2005 and, in some cases, disrupting production. In
addition, hurricane-related disruption of rail and pipeline traffic in the U.S.
Gulf Coast area negatively affected shipments of raw materials and
product.
In
addition, in light of near record raw material costs and Millennium’s current
debt levels, the cost to Millennium of trade credit from its suppliers could
increase or credit lines from those suppliers could be reduced, resulting in
shorter payment cycles.
Millennium’s
and its joint ventures’ operations and assets are subject to extensive
environmental, health and safety and other laws and regulations, which could
result in material costs or liabilities.
Millennium
and its joint ventures cannot predict with certainty the extent of future
liabilities and costs under environmental, health and safety and other laws and
regulations and whether liabilities and costs will be
material. Millennium and its joint ventures also may face liability
for alleged personal injury or property damage due to exposure to chemicals or
other hazardous substances at their current or former facilities or chemicals
that they manufacture, handle or own. In addition, because the
products of Millennium and its joint ventures are components of a variety of
other end-use products, Millennium and its joint ventures, along with other
members of the chemical industry, are inherently subject to potential claims
related to those end-use products. Although claims of the types
described above have not historically had a material impact on Millennium’s or
its joint ventures’ operations, a substantial increase in the success of these
types of claims could result in the expenditure of a significant amount of cash
by Millennium or its joint ventures to pay claims, and could reduce their
operating results.
Millennium
and its joint ventures (together with the industries in which they operate) are
subject to extensive national, state and local environmental laws and
regulations concerning, and are required to have permits and licenses
regulating, emissions to the air, discharges onto land or waters and the
generation, handling, storage, transportation, treatment and disposal of waste
materials. Many of these laws and regulations provide for substantial
fines and potential criminal sanctions for violations. Some of these
laws and regulations are subject to varying and conflicting
interpretations. In addition, some of these laws and regulations
require Millennium and its joint ventures to meet specific financial
responsibility requirements. Millennium cannot accurately predict
future developments, such as increasingly strict environmental laws, and
inspection and enforcement policies, as well as higher compliance costs, which
might affect the handling, manufacture, use, emission or disposal of products,
other materials or hazardous and non-hazardous waste. Some risk of
environmental costs and liabilities is inherent in Millennium’s and its joint
ventures’ operations and products, as it is with other companies engaged in
similar businesses, and there is no assurance that material costs and
liabilities will not be incurred. In general, however, with respect
to the costs and risks described above, Millennium does not expect that it or
its joint ventures will be affected differently than the rest of the chemical
industry where their facilities are located.
Environmental
laws may have a significant effect on the nature and scope of cleanup of
contamination at current and former operating facilities, the costs of
transportation and storage of raw materials and finished products and the costs
of the storage and disposal of wastewater. Also, U.S. “Superfund”
statutes may impose joint and several liability for the costs of remedial
investigations and actions on the entities that generated waste, arranged for
disposal of the wastes, transported to or selected the disposal sites and the
past and present owners and operators of such sites. All such
responsible parties (or any one of them, including Millennium and its joint
ventures) may be required to bear all of such costs regardless of fault, the
legality of the original disposal or ownership of the disposal site. In
addition, similar environmental laws and regulations that have been or may be
enacted in countries outside of the U.S. may impose similar liabilities and
costs upon Millennium.
Millennium
and its joint ventures have on-site solid-waste management units at several
facilities. It is anticipated that corrective measures will be
necessary to comply with federal and state requirements with respect to these
facilities. Millennium and its joint ventures also have liabilities
under the Resource Conservation and Recovery Act and various state and non-U.S.
government regulations related to several current and former plant
sites. Millennium and its joint ventures also are responsible for a
portion of the remediation of certain off-site waste disposal
facilities. Millennium and its joint ventures are contributing funds
to the cleanup of several waste sites throughout the U.S. under the
Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”)
and the Superfund Amendments and Reauthorization Act of 1986, including the
Kalamazoo River Superfund Site discussed below. Millennium and its
joint ventures also have been named as potentially responsible parties at
several other sites. Millennium’s policy is to accrue remediation
expenses when it is probable that such efforts will be required and the related
expenses can be reasonably estimated. Estimated costs for future
environmental compliance and remediation are necessarily imprecise due to such
factors as the continuing evolution of environmental laws and regulatory
requirements, the availability and application of technology, the identification
of presently unknown remediation sites and the allocation of costs among the
potentially responsible parties under applicable statutes. For
further discussion regarding Millennium’s and its joint ventures’ environmental
matters and related accruals (including those discussed in this risk factor),
and environmentally-related capital expenditures, see also “Item 1. Legal
Proceedings” and Note 13 to the Consolidated Financial Statements in this
report, and Note 18 to the Consolidated Financial Statements, “Item 1.
Business—Environmental Capital Expenditures,” “Item 3. Legal
Proceedings—Environmental Matters” and “Item 7. Management’s
Discussion and Analysis of Financial Condition and Results of
Operations—Environmental Matters” in Millennium’s Annual Report on Form 10-K for
the year ended December 31, 2007. If actual expenditures exceed the
amounts accrued, that could have an adverse effect on Millennium’s and its joint
ventures’ results of operations and financial position.
Kalamazoo River Superfund
Site—A Millennium subsidiary has been identified as a PRP with respect to
the Kalamazoo River Superfund Site. The site involves cleanup of
river sediments and floodplain soils contaminated with polychlorinated
biphenyls, cleanup of former paper mill operations, and cleanup and closure of
landfills associated with the former paper mill
operations. Litigation concerning the matter commenced by the State
of Michigan in December 1987 was recently dismissed, although the State reserved
its right to bring certain claims in the future if the issues are not resolved
in the CERCLA process.
In 2000,
the Kalamazoo River Study Group (the “KRSG”), of which the Millennium subsidiary
and other PRPs are members, submitted to the State of Michigan a Draft Remedial
Investigation and Draft Feasibility Study, which evaluated a number of remedial
options for the river. The estimated costs for these remedial options
ranged from $0 to $2.5 billion. Although the KRSG study
identified a broad range of remedial options, not all of those options would
represent reasonably possible outcomes. Management does not believe
that any single remedy among those options represented the highest-cost
reasonably possible outcome.
In 2004,
Millennium recognized a liability representing Millennium’s interim allocation
of 55% of the $73 million total of estimated cost of riverbank
stabilization, recommended as the preferred remedy in 2000 by the KRSG study,
and of certain other costs.
At the
end of 2001, the U.S. Environmental Protection Agency (“EPA”) took lead
responsibility for the river portion of the site at the request of the State of
Michigan. In 2004, the EPA initiated a confidential process to
facilitate discussions among the agency, the Millennium subsidiary, other PRPs,
the Michigan Departments of Environmental Quality and Natural Resources, and
certain federal natural resource trustees about the need for additional
investigation activities and different possible approaches for addressing the
contamination in and along the Kalamazoo River. As these discussions
have continued, management has obtained new information about regulatory
oversight costs and other remediation costs, including a proposed remedy to be
applied to a specific portion of the river, and has been able to reasonably
estimate anticipated costs for certain other segments of the river, based in
part on experience to date with the remedy currently being applied to the one
portion of the river. As a result, management can reasonably estimate
the probable spending for remediation of three segments of the river, which has
been accrued as of June 30, 2008. Management’s best estimates for
costs relating to other segments of the river, which may remain uncertain for
the foreseeable future, also have been accrued, based on the KRSG
study. As of June 30, 2008, the probable additional future
remediation spending associated with the river cannot be determined with
certainty but the amounts accrued are believed to be the current best estimate
of future costs, based on information currently
available.
In
addition, Millennium has recognized a liability primarily related to
Millennium’s estimated share of remediation costs for two former paper mill
sites and associated landfills, which are also part of the Kalamazoo River
Superfund Site. Although no final agreement has been reached as to
the ultimate remedy for these locations, Millennium has begun remediation
activity related to these sites.
See Note
13 to the Consolidated Financial Statements in this report for the information
as to the accrued liabilities related to the Kalamazoo River and the two former
paper mill sites with associated landfills.
Millennium’s
ultimate liability for the Kalamazoo River Superfund Site will depend on many
factors that have not yet been determined, including the ultimate remedies
selected, the determination of natural resource damages, the number and
financial viability of the other PRPs, and the determination of the final
allocation among the PRPs.
Other Regulatory
Requirements—In addition to the matters described above, Millennium and
its joint ventures are subject to other material regulatory requirements that
could result in higher operating costs, such as regulatory requirements relating
to the security of its facilities, and the transportation, exportation or
registration of its products. Although Millennium and its joint
ventures have compliance programs and other processes intended to ensure
compliance with all such regulations, Millennium and its joint ventures are
subject to the risk that their compliance with such regulations could be
challenged. Non-compliance with certain of these regulations could
result in the incurrence of additional costs, penalties or assessments that
could be significant.
Proceedings
related to the alleged exposure to lead-based paints and lead pigments could
require Millennium to spend material amounts in litigation and settlement costs
and judgments.
Together
with alleged past manufacturers of lead-based paint and lead pigments for use in
paint, Millennium has been named as a defendant in various legal proceedings
alleging personal injury, property damage, and remediation costs allegedly
associated with the use of these products. The plaintiffs include
individuals and governmental entities, and seek recovery under a variety of
theories, including negligence, failure to warn, breach of warranty, conspiracy,
market share liability, fraud, misrepresentation and nuisance. The
majority of these legal proceedings assert unspecified monetary damages in
excess of the statutory minimum and, in certain cases, equitable relief such as
abatement of lead-based paint in buildings. These legal proceedings
are in various trial stages and post-dismissal settings, some of which are on
appeal.
While
Millennium believes that it has valid defenses to all the lead-based paint and
lead pigment proceedings and is vigorously defending them, litigation is
inherently subject to many uncertainties. Additional lead-based paint
and lead pigment litigation may be filed against Millennium in the future
asserting similar or different legal theories and seeking similar or different
types of damages and relief, and any adverse court rulings or determinations of
liability, among other factors, could affect this litigation by encouraging an
increase in the number of future claims and proceedings. In addition,
from time to time, legislation and administrative regulations have been enacted
or proposed to impose obligations on present and former manufacturers of
lead-based paint and lead pigment respecting asserted health concerns associated
with such products or to overturn successful court decisions.
Millennium
is unable to predict the outcome of lead-based paint and lead pigment
litigation, the number or nature of possible future claims and proceedings, or
the effect that any legislation and/or administrative regulations may have on
Millennium. In addition, Millennium cannot reasonably estimate the
scope or amount of the costs and potential liabilities related to such
litigation, or any such legislation and regulations. Thus, any
liability Millennium incurs with respect to pending or future lead-based paint
or lead pigment litigation, or any legislation or regulations could, to the
extent not covered or reduced by insurance or other recoveries, have a material
impact on Millennium’s results of operations. In addition, Millennium
has not accrued any liabilities for judgments or settlements against Millennium
resulting from lead-based paint and lead pigment litigation. Any
liability that Millennium may ultimately incur with respect to lead-based paint
and lead pigment litigation is not affected by the sale of the inorganic
chemicals business, which closed on May 15, 2007. See “Item 1. Legal
Proceedings—Litigation Matters” for additional discussion regarding lead-based
paint and lead pigment litigation.
Risks
Relating to Debt
Millennium’s
available cash, access to additional capital and business and future prospects
could be limited by its significant amount of debt and other financial
obligations and the current weak condition of the capital markets.
At June
30, 2008, Millennium had $171 million of consolidated debt, including the
current portion of long-term debt. Also at that date, Millennium had
guaranteed $19.3 billion and €1.8 billion of debt of related
parties. Substantially all of the indebtedness owed or guaranteed by
Millenniums’ is secured by certain assets of Millennium pledged as
collateral. In addition, Equistar had $330 million of
consolidated debt. In addition, Millennium has contractual commitments and
ongoing pension and post-retirement benefit obligations that will require cash
contributions in the future. See “—Contractual and Other Obligations” under
“Item 7. Management’s Discussion and Analysis of Financial Condition and Results
of Operation” in Millennium Annual Report on Form 10-K for the year ended
December 31, 2007.
Millennium’s
level of debt and other obligations could have significant adverse consequences
on its business and its future prospects, including that it could:
·
|
make
Millennium more vulnerable to a downturn in its businesses, its industry
or the economy in general as a significant percentage of its cash flow
from operations is required to make payments on its indebtedness, making
it more difficult to react to changes in its business and in market or
industry conditions;
|
·
|
require
Millennium to dedicate a substantial portion of its future cash flow from
operations to the payment of principal and interest on indebtedness,
thereby reducing the availability of its cash flow to grow its business
and to fund working capital, capital expenditures, research and
development efforts and other general corporate
purposes;
|
·
|
constrain
its ability to obtain additional financing in the future for working
capital, capital expenditures, acquisitions, debt service requirements or
other purposes, on satisfactory terms or at all, especially given the
current weak environment in the capital
markets;
|
·
|
make
it more difficult for it to satisfy its financial
obligations;
|
·
|
place
it at a competitive disadvantage as compared to competitors that have less
debt and lower debt service requirements;
and
|
·
|
make
it more vulnerable to increases in interest rates since part of its
indebtedness is, and any future debt may be, subject to variable interest
rates.
|
Subsequent
to the acquisition of Lyondell, LyondellBasell Industries manages the cash and
liquidity of Millennium and its other subsidiaries as a single group and a
global cash pool. Substantially all of the group’s cash is managed
centrally, with operating subsidiaries participating through an intercompany
uncommitted revolving credit facility. The majority of the operating
subsidiaries of LyondellBasell Industries, including Millennium and Equistar,
have provided guarantees or collateral for the new debt of various
LyondellBasell Industries subsidiaries totaling approximately $22 billion that
was used primarily to acquire Lyondell. Accordingly, the major credit
rating agencies have assigned a corporate rating to LyondellBasell Industries as
a group relevant to such borrowings. Management believes this corporate rating
is reflective of the inherent credit for Millennium, as well as for the group as
a whole.
In the
event that LyondellBasell Industries’ ratings are lowered by any of the major
credit rating agencies, LyondellBasell Industries (including Millennium) may
have increased borrowing costs for trade credit and other indebtedness, and any
new financing or credit facilities, if available at all, may not be on terms as
attractive as those LyondellBasell Industries and Millennium have currently or
other terms acceptable to LyondellBasell Industries and
Millennium. LyondellBasell Industries’ operating subsidiaries
(including Millennium) also could be required to provide cash collateral to
obtain surety bonds or other forms of credit, which would reduce available cash
or require additional financing.
For a
discussion regarding Millennium’s ability to pay or refinance its debt, see the
“—Liquidity and Capital Resources” section under “Item
7. Management’s Discussion and Analysis of Financial Condition and
Results of Operations.”
The
substantial level of indebtedness and other financial obligations of Millennium,
as well of LyondellBasell Industries generally, also increases the possibility
that Millennium, or another borrower whose obligations are guaranteed by
Millennium, may be unable to generate cash sufficient to pay, when due, the
principal of, interest on or other amounts due in respect of its indebtedness
and other financial obligations. If Millennium, or another borrower
for which Millennium or one of its subsidiaries is a guarantor, were unable to
pay principal and interest on debt, a default would exist under the terms of
that debt instrument, which could have significant adverse consequences for
Millennium. See “Failure to comply with debt covenants or to pay
principal and interest when due could result in an acceleration of
debt.”
Millennium’s
variable rate obligations subject it to interest rate risk and in addition
interest rates under the Senior Secured Interim Loan are subject to increase for
other reasons, which could cause its debt service obligations to increase
significantly.
As of
June 30, 2007, Millennium was an obligor with respect to variable rate
borrowings under the Senior Secured Credit Facilities and the Senior Secured
Interim Loan of approximately $20,622 million. Although
Millennium and its co-obligors may have interest rate hedge arrangements in
effect from time to time, its interest expense could increase if interest rates
increase, because its variable rate obligations may not be fully hedged and they
bear interest at floating rates, generally equal to adjusted Euro Interbank
Offered Rate (“EURIBOR”) and LIBOR plus an applicable
margin. Additionally, the Senior Secured Credit Facilities and the
Senior Secured Inventory-Based Credit Facility may bear interest at an alternate
base rate plus an applicable margin. In addition, the Senior Secured
Interim Loan bears interest at LIBOR plus an initial margin of 4.625%, which
margin increased in June 2008 to 5.125%, and increases by 0.5% for each
three-month period thereafter, subject to a maximum interest rate of 12% per
annum (or 12.5% in the event of certain ratings declines). Through a
series of actions, the validity of which LyondellBasell Industries disputes, the
joint lead arrangers of the Senior Secured Interim Loan have attempted to
increase the applicable rate under the Senior Secured Interim Loan to 12% per
annum. Since June 20, 2008, LyondellBasell Industries has been
paying 12% interest, which is approximately 4% higher than the currently applicable
rate under the Senior Secured Interim Loan as at June 20, 2008, in order to
avoid any allegation of default by the lenders. LyondellBasell
Industries has protested the higher rate of interest and has reserved its right
to recover any such amounts based upon a determination that the joint lead
arrangers’ attempt to impose a rate increase is not supported by the terms of
the applicable loan documentation. A 0.5% increase in the interest
rate on variable rate obligations as of June 30, 2008 would cost Millennium
approximately $2 million per year in incremental interest
expense.
Item
6. Exhibits
4.2
|
|
Amended
and Restated Senior Secured Credit Agreement Dated as of April
30, 2008 (filed as an exhibit to Lyondell Chemical Company’s Current
Report on Form 8-K filed on May 6, 2008 and incorporated herein
by reference)
|
|
|
|
4.3
|
|
Amended
and Restated Bridge (Interim) Loan Credit Agreement Dated as of
April 30, 2008 (filed as an exhibit to Lyondell Chemical Company’s
Current Report on Form 8-K filed on May 6, 2008 and incorporated herein by
reference)
|
|
|
|
4.5(a)
|
|
Amended
No. 1 to Senior Secured Inventory-Based Credit Agreement Dated as of
April 30, 2008 (filed as an exhibit to Lyondell Chemical Company’s
Current Report on Form 8-K filed on May 6, 2008 and incorporated
herein by reference)
|
|
|
|
10.7(a)
|
|
First
Supplement to Amended and Restated Limited Partnership Agreement (filed as
an exhibit to the Registrant’s Current Report on Form 8-K filed on April
14, 2008 and incorporated herein by reference)
|
|
|
|
10.8
|
|
Indemnity
Agreement with Equistar (filed as an exhibit to the Registrant’s Current
Report on Form 8-K filed on April 14, 2008 and incorporated herein by
reference)
|
|
|
|
31.1
|
|
Rule
13a – 14(a)/15d – 14(a) Certification of Principal Executive
Officer
|
|
|
|
31.2
|
|
Rule
13a – 14(a)/15d – 14(a) Certification of Principal Financial
Officer
|
|
|
|
32.1
|
|
Section
1350 Certification of Principal Executive Officer
|
|
|
|
32.2
|
|
Section
1350 Certification of Principal Financial
Officer
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
Millennium
Chemicals Inc.
|
|
|
|
|
|
|
Dated: August
14, 2008
|
|
/s/
Eberhard Faller
|
|
|
Eberhard
Faller
|
|
|
Vice
President, Controller
and
Chief Accounting Officer
|
|
|
(Duly
Authorized and
Principal
Accounting Officer)
|